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Superantigens are exotoxins produced by Staphylococcus aureus and induce 
extensive T cell proliferation and proinflammatory cytokines, leading to toxic shock 
syndrome at high concentrations. However, the role of superantigens produced at 
relatively low concentrations during asymptomatic colonization or chronic infection has 
not been well established. In this dissertation, we demonstrated that stimulation of human 
PBMCs with staphylococcal enterotoxin C1 (SEC1) at the dose inducing a half maximal 
T cell proliferation (suboptimal stimulation) induced immunosuppressive 
CD4+CD25+FOXP3+ and CD8+CD25+FOXP3+ T cells. The suppression of these cells 
was mainly mediated by the galectin-1. We found that suboptimal stimulation with SEC1 
induced differential activation of PI3K-mTOR-Akt pathway, leading to expression of 
FOXP3 isoforms preferably localized to the nucleus and induction of PTEN that 
contributes to maintain stability and suppressive activity of regulatory T cells. Taken 
together, these results demonstrate the important role of superantigen produced at low 
concentration during asymptomatic colonization that induce immunosuppressive CD4+ 
 
 
and CD8+ regulatory T cells to promote survival, propagation, and colonization for S. 
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INTRODUCTION AND REVIEW OF RELAVANT LITERATURE 
1.1 Introduction 
Staphylococcus aureus (S. aureus) is a gram-positive coccus frequently 
colonizing skin, nasal mucosa, and respiratory tract of humans. It causes a multitude of 
diseases from mild soft tissue infections to life threating diseases such as infective 
endocarditis, sepsis, necrotizing pneumonia, and toxic shock syndrome (TSS) [1]. 
Approximately 30-40 % of people are colonized asymptomatically at any given time and 
70 % of people experience S. aureus infection without any symptoms in their lifetime [1]. 
Pathogenesis of S. aureus infection is mediated by various virulence factors, among 
which the staphylococcal superantigens play a critical role on host immune responses. 
Superantigens (SAgs) are classically known to modulate host immune responses 
by their properties to activate enormous number of T cells, leading to cytokine storms 
and anergy following activation-induced cell death [1]. The pathologic role of SAgs is 
well characterized in toxic shock syndrome (TSS) at which a large amount of SAgs 
ranging from 1 to 10 µg/ml were produced [2]. However, in chronic infections or 
asymptomatic colonization, S. aureus produces a small quantity of superantigens that 
hardly induce detectible level of serum antibodies [3-5] and the role of such small amount 
of SAgs in the S. aureus pathogenesis has not been clearly demonstrated yet. 
Furthermore, several population genomic studies demonstrated that the most prevalent 
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SAg genes in S. aureus clinical isolates are the enterotoxin gene cluster SAgs (SEG, SEI, 
SElM, SElN, SElO) of which expression is intrinsically regulated to at low amounts [6]. 
Regulatory T cells (Tregs) play an important role in maintaining immune 
homeostasis and preventing autoimmune diseases [7-10]. However, pathogens can 
exploit Tregs to establish infection by suppressing host immune response. Importantly, 
suboptimal stimulation of T cell induce development of Treg in thymus and periphery. 
These suggest that a low amount of SAgs produced by S. aureus might induce Treg to 
promote its colonization and pathogenesis which have not been clearly demonstrated yet. 
1.2 Regulatory T cells 
1.2.1 Brief history 
The presence of immunoregulatory mechanisms that control peripheral immune 
tolerance against self-reactive immune cells had been suggested before discovery of 
Tregs. Studies in 1970s showed that thymus-derived lymphocytes seemed to contribute to 
control of autoimmune diseases, as thymectomized mice and rats developed severe 
autoimmune diseases, which could be prevented by transfer of T cells from normal mice 
or rats [11-13]. However, efforts to identify the suppressive T cells failed due to 
difficulties in discovering specific marker and suppression mechanisms, and even in 
preparation of suppressive T cells until identification of CD25 (IL-2 receptor α chain) as 
a specific marker of the suppressive CD4+ T cells by Sakaguchi et al in 1995 [14]. The 
role of CD4+CD25+ T cells on maintaining immune tolerance was clearly demonstrated 
in mice, followed by identification of counterpart CD4+CD25+ T cells in humans in 
2001 [15, 16]. 
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To identify molecular mechanisms of Treg development, researchers had focused 
on genetic defects in recessive inflammatory diseases observed in scurfy mice [17] and 
IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome in 
humans [18]. Genetic analysis revealed that a single gene mutation in a transcription 
factor, forkhead box P3 (Foxp3), in scurfy mice rapidly developed fatal autoimmune 
diseases [19]. Immediately, mutations of human FOXP3 in IPEX patients were identified 
[18, 20], which suggested possible role of Foxp3 in immunoregulation. Subsequent 
studies determined that Foxp3 was undoubtedly a key transcription factor for 
CD4+CD25+ Tregs. High expression of Foxp3 mRNA was detected in CD4+CD25+ T 
cells and ectopic expression of Foxp3 conferred Treg-like phenotype and functionality on 
peripheral CD4+CD25- T cells [21, 22]. Eventually, the suppressive CD4+ T cells were 
defined as CD4+CD25+FOXP3+ regulatory T cells. 
Subsets of CD8+ T cells suppressing immune responses have been introduced in 
1970 [23], but CD8+ Tregs had been left behind until discovery of CD4+ Tregs due to 
high heterogeneity in cell phenotypes and lack of knowledge about the suppression 
mechanism. Still, the phenotypic characteristics of CD8+ Tregs are much broader 
depending on the induction methods and no unique marker has been described yet, even 
Foxp3. Although lack of CD28 expression has been suggested as a marker for CD8+ 
Tregs [24], CD8+CD28+ T cells with suppressive activity are present in mice and 
humans [8, 25]. Knowledge on CD8+ Tregs is growing, especially as it relates to clinical 
significance in autoimmune diseases and cancer. 
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1.2.2 Subsets of regulatory T cells 
Following the current nomenclature recommendation [11], Tregs can be classified 
based on the anatomical origin of cells. Tregs are primarily generated from thymus 
(thymus-derived Tregs, tTregs) that survived thymic selection. Tregs also can be induced 
from naïve T cells by stimulation in periphery (pTregs). Tregs induced by in vitro 
stimulation of naïve T cells are termed in vitro-induced Tregs (iTregs) to distinguish 
them from pTregs. It remains unclear whether pTregs and iTregs represent identical 
subpopulations. The presence of TGF-β is essential to induce iTregs in mice whereas 
human iTregs can be induced without addition of TGF-β. It is suggested that suppression 
mechanisms employed by tTregs and iTregs may differ [12]. tTregs appear to play a 
primary role in preventing differentiation of T cells into pathogenic Th1 cells and 
regulating effector T cell trafficking in vivo [13, 14]. Meanwhile, iTregs modulate DC 
function by producing IL-10 and downregulating costimulatory molecules, thereby 
inhibiting effector T cell functions [15]. Antigen-specific iTregs seem more effective to 
prevent and treat organ specific autoimmunity than tTregs in mouse model study [16].  
1.2.3 FOXP3 
FOXP3 is a transcription factor indispensable for Treg development and function. 
Mutations in FOXP3 gene result in deficiency in functional Tregs and severe multi-organ 
immune disorder such as scurfy syndrome in mice [26] and IPEX (immune 
dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome in humans [27], 
indicating an essential role of FOXP3 in Treg function. The FOXP3 gene consists of 12 
exons, but the first exon is not translated. Hence, FOXP3 gene is generally considered to 
have 11 exons that encodes a protein consisting of several functional domains including a 
 
5 
N-terminal domain, a C2H2 zinc finger, a leucine zipper, and a winged-helix/forkhead 
DNA binding domain. FOXP3 isoforms by alternative splicing have been identified in 
human Tregs while only full-length protein is reported in the mouse counterpart. Thus 
far, FOXP3 isoforms lacking exon 2 (ΔE2), exon 7 (ΔE7), and exon 2 and exon 7 
(ΔE2ΔE7) have been reported [28-30]. Exon 2 is a part of proline-rich region at N-
terminal domain of FOXP3 that interact with RORα and RORt. Exon 7 is part of leucine 
zipper domain necessary for FOXP3 homodimerization. ΔE2ΔE7 does not affect 
dimerization but abrogate suppressive activity [28, 31]. The function of FOXP3ΔE7 
remains unknown [30].  
 
Figure 1.1 FOXP3 structure and its binding partners. 
ROR: RAR-related orphan receptor, HDAC: Histone deacetylase, RUNX1: Runt-related transcription 
factor 1, NFAT: Nuclear factor of activated T cells 
FOXP3 binds to more than 2000 genes differentially expressed in Tregs and 
suppresses or promotes expression of target genes [32, 33]. Proteomic study further 
revealed that FOXP3 forms a large functional complex of ~600 kDa with more than 300 
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proteins including transcriptional factors [34]. These interactions are implicated in 
various biological processes such as DNA binding, transcription regulation, and 
chromatin modification [35, 36]. (Figure 1.1). For example, the N-terminus of FOXP3 
interacts with c-Jun and inhibits its nuclear localization, subsequently downregulating 
cell activation process and maintaining unresponsiveness [37]. The exon 1-encoding 
region located in N-terminal domain of FOXP3 interacts with c-Rel, a member of NF-κB, 
and suppress gene expression of proinflammatory cytokines such as IL-2, IL-12, and 
IFN-γ [38]. Also, the exon 2-encoding region, lacking in the ΔE2 isoform, is shown to 
antagonize Th17 development by interacting RORα and RORγt [39]. When NFAT binds 
to forkhead domain of FOXP3, this represses IL-2 expression and upregulates expression 
of Treg-phenotypes such as CTLA-4 and CD25 [40]. 
FOXP3 localization is regulated by multiple factors. Nuclear import sequence is 
reported as arginine-lysine-lysine-arginine (RKKR) sequence located in forkhead domain 
[41, 42]. It is also suggested that FOXP3 translocation may be achieved by interacting 
with other transcriptional factors and co-transporting with them [43]. Nuclear export 
signal sequences are predicted to be present in boundary zone of exon 1 and 2, and exon 
6 and 7, respectively. Thus, FOXP3 ΔE2 is preferably localized to the nucleus, while full 
length FOXP3 is preferably localized to cytoplasm [42]. Several studies demonstrated 
expression of FOXP3 ΔE2 in tTreg and iTreg are higher than other Foxp3 isoforms, 
suggesting an important role of FOXP3 ΔE2 localized in the nucleus for functional 
maturation of Treg [28, 44]. However, the role of FOXP3 ΔE2 is still controversial. 
Transduction of ΔE2 using retroviral vector in primary CD4+CD25- T cells resulted in 
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suppressive activity [28, 45] or not [29]. These results suggest that expression of FOXP3 
is necessary but not sufficient for the functional maturation of Treg. 
1.2.4 Induction of FOXP3 expression 
Despite extensive research, the underlying mechanisms of Tregs induction remain 
elusive. During thymic selection, some CD4+CD25+ thymocytes survived negative 
selection and become CD4+CD25+Foxp3+ tTregs [46]. These CD4+CD25+Foxp3+ 
thymocytes have moderate to low affinity to self-antigen, suggesting the strength of TCR 
stimulation modulated by the affinity of TCR to antigen seems to play an important role 
in Tregs induction [47-49]. Similar to these findings, stimulation of murine CD4+ T cells 
with a low dose of specific or non-specific antigen to TCR in the presence of dendritic 
cells induced immunosuppressive CD4+CD25+ Foxp3+ Tregs, while a high dose 
stimulation induced CD4+CD25+ effector T cells [47]. In humans, a low dose antigen 
promotes induction and proliferation of antigen-specific FOXP3+ Tregs whereas a high 
dose antigen favors to generate FOXP3- effector T cells [50].  
The signaling downstream of TCR via PI3K, p110α, p110δ, Akt, and mTOR play 
an important role in expression of Foxp3 in tTreg and iTreg. Inhibition of these signaling 
pathways induced expression of Foxp3 and Treg-like mRNA and miRNA profiles [51]. 
On the contrary, constitutive activation of the PI3K/AKT/mTOR pathways in PTEN 
deficient T cells significantly reduced Foxp3 expression [52]. The role of co-stimulatory 
signal through CD28 is controversial. As the CD28-deficient mice have ~80% reduced 
thymic CD4+CD25+Foxp3+ Tregs, costimulatory signals via CD28 seems to be 
important for induction of tTregs [53]. In contrast, strong activation of CD28 via anti-
CD28 antibody inhibits induction of Foxp3. Indeed, activation of TCR and CD28 by a 
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low dose of antigen and anti-CD28, followed by TCR signal deprivation and 
PI3K/mTOR inhibition induced higher expression of Foxp3 [51]. These results suggest 
that expression of Foxp3 is regulated by the timing of PI3K/AKT/mTOR pathways 
inhibition upon activation of T cell via TCR signaling [51]. Major cytokines involved in 
Tregs induction are IL-2 and TGF-β [54, 55]. Binding of IL-2 to its receptor induces 
activation of signal transducer and activator of transcription 5 (STAT5), which binds to 
the promoter and enhancer region of FOXP3 [55]. TGF- β1 signaling promotes the 
binding of nuclear factor of activated T cells (NFAT) and mothers against 
decapentaplegic homologue 3 (SMAD3) to the enhancer region of FOXP3 and in turn 
control epigenetic regulation of Foxp3 [56, 57].  
1.2.5 Mechanisms of regulatory T cell-mediated suppression 
Diverse suppression mechanisms (Table 1.1 and 1.2) have been proposed for Treg 
depending on the type of Tregs (tTregs, pTregs, iTregs), induction mechanism (anti-
CD3/CD28 beads, antibodies, soluble antigens, and superantigens), and species (human, 
mouse). The suppression mechanism can be broadly classified into two categories: cell-
to-cell contact-dependent and -independent suppression. The cell-to-cell contact-
dependent suppression requires direct interactions between Tregs and effector T cells 
and/or antigen presenting cells (APCs). On the other hand, contact-independent 
suppression is mediated by soluble factors such as immunosuppressive 
cytokines/chemokines, cytolytic molecules, and changes in microenvironment necessary 




Table 1.1 Suppression mechanisms of CD4+ Tregs 
Key 
molecule 
Species Type Induction Mechanism Ref. 
INHIBITORY CYTOKINE S AND CHEMOKINES 
CCL3/4 mouse thymic  
Attracts CCR5+ T cells in vivo 
Inhibits TCR signaling by inhibiting 
Ca2+ flux in T cells 
[60] 
TGF-β 
human adaptive SEB, TGF-β Inhibit T cell proliferation by repressing 
gene expression of cytokine receptors and   
by inducing cbl-b 
Induce apoptosis via pro-apoptotic bcl-2 
family proteins 
Surface-bound TGF-β complexed with 




thymic  [62] 




Downregulates costimulatory molecules 








thymic  [66, 67] 





Inhibits T cell proliferation and 
production of proinflammatory cytokines 
[68] 
mouse thymic  [66, 69] 
CYTOLYTIC MOLECULES 
Granzyme B 
human thymic  Induces apoptosis in effector T cells, 
dendritic cells, and natural killer cells in 
both a perforin-dependent and -
independent manner 
[70] 
mouse thymic  [71] 
Galectin-1 human thymic  
Triggers Ca2+ efflux, leading to arrest 
and apoptosis of activated effector T cells 
[72] 
Galectin-3 human thymic  
LGALS3 mRNA is highly expressed in 
human Tregs but the functionality has not 




Binds to DR3 (TNFRSF25) expressed on 




injection to induce 
hepatitis 
[76] 
Galectin-10 human thymic  
Treatment of galectin-10-specific siRNA 
results in partial abrogation of Treg 




COX2 human adaptive 
SEB, anti-CD3/anti-
CD28, immature 
DC, tumor cells 
(COX2+/-), IL-2, 
IL-10, and IL-15 
Facilitate production of PGE2 which 
binds to EP2 and EP4 receptors, inducing 
upregulation of intracellular cAMP 
[78, 79] 
CD39/CD73 
human thymic  Cleave ATP sequentially into adenosine 
which binds to A2A receptors expressed 
on conventional T cells, leading to 
upregulation of intracellular cAMP 
[80, 81] 
mouse thymic  [82] 
cAMP mouse thymic  
Downregulates proinflammatory 
cytokines expression in T cells and APCs 
and CD80/CD86 expression by DCs 
Suppression is mediated by transfer of 









induced by tTregs 
IDO expression in DCs is induced by 
tTregs through CTLA-4 dependent 
mechanism 
IDO facilitate tryptophan metabolism, 
which induces production of pro-
apoptotic metabolites such as kynurenine 
[85] 
adaptive 
Repeated in vivo 
injection of SEB 
[86] 
CONTACT-DEPENDENT SUPPRESSIVE MOLECULES 
CTLA-4 mouse thymic  
Binds to CD80/CD86 on APCs with 
higher affinity than CD28, inducing 
downregulation of CD80/CD86. CTLA-4 
ligation also induces IDO expression in 
DCs 
[87, 88] 
PD-1 mouse adaptive 
LCMV chronic 
infection 
Binds to PD-L1 and induces inhibitory 
signal, preventing activation and 





human thymic  LFA-1 on Tregs interact with ICAM-1 on 
DCs, inhibiting CD80 and CD86 
expressions in DCs 
[90] 
mouse thymic  [91, 92] 
LAG-3 mouse thymic  
Binds to MHC class II molecules with a 
higher affinity than CD4 and induces 
ITAM-mediated inhibitory signals, 
thereby downregulating DC function 
[93] 
neuropilin-1 mouse thymic  
Promote prolonged interactions of Tregs 




human thymic  
Binds to Fas receptor and induces 
cytolysis of effector T cells and DCs 
[97, 98] 
mouse thymic  Alter DC function [99] 
TRAIL mouse thymic  
Induces T cell death via TRAIL-DR5 
pathway 
[100] 
COX2: Cyclooxygense-2, IDO: Indolamine-2,3-dioxygenase, LCMV: lymphocytic choriomeningitis virus, 
TRAIL: TNF-related apoptosis-inducing ligand, DR5: Death receptor 5 
Table 1.2 Suppression mechanisms of CD8+ Tregs 
Key 
molecule 
Species Type Induction Phenotype Mechanism Ref. 
INHIBITORY CYTOKINES AND CHEMOKINES 






Inhibit TCR signaling 
by inhibiting Ca2+ 

































Table 1.2 (Continued) 
TGF-β 
human thymic  CD8+CD25+ Inhibit T cell 
proliferation by 
repressing gene 
expression of cytokine 
receptors and inducing 
cbl-b 


























In SLE patient, IL-6 
also involves in 
suppression 
Mediates suppression 


















to T cells 
[114] 




Induces ROS in CD4 
T cells, inhibiting 
phosphorylation of 
ZAP70 and LAT 
[115] 
CONTACT-DEPENDENT SUPPRESSIVE MOLECULES 
CTLA-4 
human thymic thymocytes CD8+CD25+ Alter CD80/86 
expression on DCs and 















Induce ILT-3 and ILT-
4 on APC which 
induce T cell anergy 
[117] 
unknown 
human adaptive SEB 
CD8+CD25+ 
FOXP3+ 



















pDC: plasmacytoid dendritic cell, NOX2: NADPH oxidase 2, TW: transwell 
1.2.6 Regulatory T cells in mice and humans 
Mice have been an essential model for characterizing Tregs in vivo. The Tregs in 
mice and humans share common features including; 1) expression of Foxp3 in 
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CD4+CD25+ T cells; 2) induction from thymus (tTreg) and periphery (pTreg); 3) 
suppression by cell-to-cell contact dependent and independent-manner. However, there 
are some fundamental differences between mice and human Tregs. The most prominent 
and significant differences are in Foxp3. In mice, Foxp3 is exclusively expressed in 
tTregs and pTreg which allows Foxp3 as a definite marker for Tregs in mice [20, 121]. 
By contrast, in humans, FOXP3 can be transiently expressed in CD4+CD25+ T cells 
without immunosuppressive function [122, 123]. Whereas mice only express a single 
form of Foxp3 as in full length, humans express various Foxp3 isoforms as described 
above [30, 44, 124] and it is not clearly demonstrated yet which Foxp3 isoforms are 
critical for development and maturation of Tregs in humans. Thus, Foxp3 cannot be an 
exclusive marker for functional Tregs in humans.  
The suppression mechanisms are likely to differ between mouse and human Tregs 
as described in Table 1.1 and 1.2. Not all suppressive molecules found in one species can 
be applied in the other species. Some suppressive mechanisms such as via CTLA-4 and 
LAG-3 have only shown in mouse models. In the case of IL-35, mouse tTregs 
constitutively express IL-35 whereas human Tregs do not express IL-35 unless stimulated 
with IL-35 provided from other cells [68, 125]. Neuropilin-1 is suggested as a distinct 
cell surface marker to differentiate tTregs from pTregs in mice [95], but in humans, 
neuropilin-1 is upregulated in activated T cells [96]. Neuropilin-1 plays a role, not only in 
maintaining prolonged Tregs-DC interaction [94-96] but in capturing a latent form of 
TGF-β and convert it to an active form [126], indicating importance of neuropilin-1 on 
TGF-β-mediated suppression mechanism. Therefore, being aware of differences between 
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mouse and human Tregs is required to minimize confusion on understanding physiology 
and functionality of Tregs.  
1.2.7 Regulatory T cells in infection 
In infectious disease, immune responses to pathogens can result in severe damage 
to host tissues. Tregs play an essential role in controlling such immunopathological 
processes. Tregs suppress robust immune responses to infections, thereby promoting 
microbial persistence that arises via the balance between inflammatory immune responses 
and immunosuppression by Tregs [127]. While most pathogens have developed multiple 
strategies to evade from host immune systems, they may favor to utilize Tregs for their 
survival. In fact, Tregs become fully functional featured by enhanced production of 
immunomodulatory cytokines such as IL-10 and TGF-β upon activation with microbial 
antigens [128, 129]. Since TGF-β is essential not only for maintenance of Tregs function 
but for induction of Tregs from conventional T cells, the microenvironment surrounding 
activated Tregs in certain microbial infection may provide more favorable condition to 
Tregs. 
The immunomodulatory effect by Tregs has been understood in pathogens that 
cause chronic infection. Increased Tregs population has been reported in patients 
chronically infected with Helicobacter pylori [65, 130, 131] or Mycobacterium 
tuberculosis [132]. Children with nasopharyngeal carriage of Streptococcus 
pneumococcus had higher portion of Tregs in adenoidal tissues [133]. In addition to 
bacterial infections, increased population of CD4+ and CD8+ Tregs have been reported 
in chronic and acute viral infections [134-138], parasite chronic infections [139-141], and 
fungal infections [142, 143]. 
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1.3 Staphylococcal superantigens 
1.3.1 Classification and structures 
Staphylococcal superantigens are a family of at least 24 serologically distinct 
proteins including toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxins 
(SEA to SEE), and SE-related toxins (SEG to SEI, SElJ, SEK to SET, SElU, SElV, SElX, 
and SElY) [1, 144, 145]. All superantigens share common protein domains that 
contribute to their superantigenicity by binding to MHC class II molecules and TCRs 
although the detailed interactions vary. Superantigenicity comes from the ability of 
superantigens binding to outside of peptide binding groove of MHC class II molecules 
and variable regions of TCR β chains (Vβ), unlike conventional antigens specifically 
recognized by antigen recognition sites of TCRs. Binding to TCR Vβ sequences provides 
diverse levels of Vβ specificity [146-148]. Affinity to MHC class II molecules also varies 
depending on their structures. Some superantigens that contain only one binding site to 
MHC class II α chain show low affinity to MHC class II molecules while other 
superantigens can bind to α- and β-chain of MHC class II molecule with higher affinity. 
Although the range of Vβ specificity does not appear to determine the strength of 
superantigenicity, superantigens with high affinity to MHC class II molecules can elicit 
stronger immune responses [1]. Recent studies demonstrated that superantigens also bind 
to receptors other than TCR and MHC II. Most staphylococcal superantigens have a short 
12-14 long-peptide sequence called dodecapeptide binding region between the domains 
mediating binding to the TCR and MHC II [149, 150]. This dodecapeptide binding region 
mediates interaction with CD40 on B cells, CD28 on T cells, and unknown receptors on 
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epithelial cells and provide co-stimulatory signals for inducing proinflammatory 
cytokines associated with toxic shock syndrome [1, 151]. 
1.3.2 Superantigen-triggered immune responses 
Binding of superantigens evokes activation of T cells by signaling mainly through 
TCR and CD28. Signaling cascades downstream of TCR and CD28 eventually induce 
activation of transcription factors, such as NFAT, NF-κB and AP-1, leading to 
upregulation of proinflammatory cytokines expression, such as IL-2 and IFN-γ [152]. 
Superantigens simultaneously activate APCs such as monocytes and macrophages to 
produce IL-1β and TNF-α which augment proinflammatory responses in concert with T 
cell responses [152]. Conventional antigens generally lead to activation of less than 0.01 
% of T cell population in the periphery whilst superantigens can activate 20-30 % of T 
cells due to its ability to bind to TCR Vβ sequences, independent of the antigen 
recognition site [147]. Therefore, superantigens evoke massive cytokine production from 
activated T cells and APCs, in turn generating overwhelming immune responses. This is 
responsible for the clinical symptoms caused by superantigens, especially in the form of 
toxic shock syndrome accompanying symptoms such as hypotension, fever, and rash [2]. 
Eventually, activated T cells undergo activation-induced cell death and depletion of 
superantigen-reactive T cells, leading to unresponsiveness of the immune system against 
second introduction of superantigens. Also, the remaining superantigen-reactive T cells 
become unresponsiveness to a secondary superantigen challenge, which is termed as 
anergy [153]. This is a classically understood mechanism of superantigen-mediated 
immunosuppression [146, 154]. 
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1.3.3 Superantigens and regulatory T cells 
In addition to depletion of reactive T cells following the extensive immune 
reaction as described above, previous studies revealed that repeated injection of bacterial 
superantigens could induce specific T cell unresponsiveness achieved by IL-10 and/or 
TGF-β producing T cells. Injection of SEB resulted in unresponsiveness against 
secondary injection, conferred by suppressive CD8+ T cells [155]. These cells suppressed 
proliferation of SEB-reactive T cells, indicating the specificity of suppresion along with 
the finding of Jiang et al. which showed that CD8+ T cells after SEB injection 
specifically deleted CD4+ T cells bearing SEB-reactive TCR Vβ sequences [156]. 
Feunou et al. demonstrated that repeated injection of SEB induced CD4+CD25- T cells 
that can suppress SEB-specific primary T cells responses [157]. Immunosuppression 
conferred by CD4+CD25- T cells was independent with CD4+CD25+ tTregs since 
transfer of unresponsive CD4+CD25- T cells protected the thymectomized mice from 
SEB-induced shock. They also demonstrated that immunosuppresion by CD4+CD25+ 
Tregs induced after repeated injection of SEB was mediated by CTLA-4, enhancing 
expression and function of IDO in DC [86]. Noel et al. showed that unresponsive CD4+ 
T cells generated after repetitive injection of SEB suppresed the production of IL-2 and 
IFN-γ following SEB treatment in vivo and in vitro, mediated by IL-10 [7]. In another 
study using transgenic mice that have TCR repertories limited specifically to SEA or 
SEB, CD4+CD25+ T cells and CD4+CD25- T cells isolated from the mice after 
superantigens treatment were functionally suppressive and the suppession was strictly 
contact-dependent [8]. The authors also demonstrated that CD4+CD25- T cells could 
acquire regulatory properties after supernantigen stimulation in the absence of tTregs. In 
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the report of Miller et al., in vivo SEA-challenged CD4+ T cells produced IL-10 and 
TGF-β that inhibited IL-2 production in naïve responder T cells [158]. 
In vitro stimulation with superantigens also induce a subset of T cells with 
regulatory function. Taylor et al. demonstrated that stimulation of human PBMCs with 
1ng/ml of staphylococcal and streptococal superantigens could induce funtional 
CD4+CD25+FOXP3+ and CD8+CD25+FOXP3+ Tregs [10, 119]. Stimulation of human 
PBMCs with SEB (3 µg/ml) could induce CD8+ Tregs with strong contact-dependent 
suppressive activity [9]. However, the effect of superantigen concentration was not 
demonstrated in these studies. 
Collectively, Tregs appear to be invovled in superantigen-induced 
unresponsiveness of immune responses after superantigen exposure. Yet the mechanisms 
of superantigen-mediated Tregs induction regarding superantigen dose relavant to 
biological conditions and direct link between colonized S. aureus and superantigen-
mediated immuosuppression has not been demonstrated. 
1.4 Objective and significance of this dissertation 
S. aureus commonly colonizes skins and mucosal membranes and sudden 
development of severe invasive staphylococcal infection can occur in 
immunocompromised patients or even in healthy individuals. However, the mechanism 
of pathogenesis is not well established yet. In this study, we aimed to identify the 
molecular mechanisms by which superantigens produced by colonized S. aureus 




First, characterize concentration-dependent effect of superantigens. The role of 
superantigens has been focused on toxic shock syndrome or food poisoning which is 
hardly related to onset of invasive staphylococcal diseases. Colonized S. aureus produces 
relatively low concentration of superantigens, therefore, demonstrating how small 
quantity of superantigens contribute to the immune response could provide understanding 
of superantigen-mediated staphylococcal pathogenesis. 
Second, identify development of CD8+ regulatory T cells by superantigens. 
Superantigens bind to and activate CD4+ T cells in TCR Vβ-specific manner and this is 
well described. In contrast, although CD8+ T cells respond to superantigens and 
proliferate as well, the knowledge of how superantigens interact with CD8+ T cells is 
lacking. Hence, studying CD8+ T cell biology in response to superantigens could 
advance our knowledge on staphylococcal superantigens. 
Third, identify the suppression mechanisms by which superantigen-induced Tregs 
inhibit effector T cell proliferation. The mechanisms can vary depending on Treg 
induction condition and species (human/mouse). Therefore, identifying the suppression 
mechanisms could provide knowledge for therapeutic strategies in S. aureus infection. 
Lastly, identify the concentration-dependent effects of superantigen in molecular 
level. Although the importance of antigen concentration on T cell differentiation has been 
described, the molecular mechanisms remain elusive. Studies on signaling pathways have 
been performed in mouse models, but the parallel study in humans is limited. Also, due to 
differences in humans and mouse, especially FOXP3 biology, identification of signaling 
pathways and FOXP3 is necessary in humans. Furthermore, this approach could advance 




INDUCTION OF IMMUNOSUPPRESSIVE CD8+CD25+FOXP3+ REGULATORY  
T CELLS BY SUBOPTIMAL STIMULATION WITH  
STAPHYLOCOCCAL ENTEROTOXIN C1 [159] 
Copyright 2018. The American Association of Immunologists, Inc. 
2.1 Abstract 
Superantigens (SAgs) produced by S. aureus induce proliferation of T cells 
bearing specific TCR Vβ sequences and massive cytokinemia that cause toxic shock 
syndrome at high concentrations. However, the biological relevance of SAgs produced at 
very low concentrations during asymptomatic colonization or chronic infections is not 
understood. In this study, we demonstrate that suboptimal stimulation of human PBMCs 
with a low concentration (1 ng/ml) of staphylococcal enterotoxin C1 (SEC1), at which 
half-maximal T cell proliferation was observed, induced CD8+CD25+ T cells expressing 
markers related to regulatory T cells (Tregs) such as IFN-γ, IL-10, TGF-β, FOXP3+, 
CD28+, CTLA4+, TNFR2+, CD45RO+, and HLA-DR+. Importantly, these 
CD8+CD25+ T cells suppressed responder cell proliferation mediated by contact-
dependent and soluble factor-dependent manners, involving galectin-1 and granzymes, 
respectively. By contrast, optimal stimulation of human PBMCs with a high 
concentration (1 μg/ml) of SEC1, at which maximal T cell proliferation was observed, 
also induced similar expression of markers related to Tregs including FOXP3 in 
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CD8+CD25+ cells, but these T cells were not functionally immunosuppressive. We 
further demonstrated that SAg induced TCR Vβ- and MHC II-restricted expansion of 
immunosuppressive CD8+CD25 T cells is independent of CD4+ T cells. Our results 
suggest that the concentration of SAg remarkably affects the functional characteristics of 
activated T cells, and low concentrations of SAg produced during asymptomatic 
colonization or chronic S. aureus infection induce immunosuppressive CD8+ regulatory 
T cells, potentially promoting colonization, propagation, and invasion of S. aureus in the 
host. 
2.2 Introduction 
Staphylococcus aureus causes some of the most critical infectious disease 
problems in the United States [160]. Annually, S. aureus accounts for approximately 
5,000 cases of toxic shock syndrome (TSS), 70,000 cases of pneumonia, 40,000 cases of 
infective endocarditis (IE) and more than 500,000 post-surgical infections, resulting in 
12,000 fatalities. Moreover, the increasing occurrence of methicillin resistant S. aureus 
(MRSA) with reduced sensitivity to vancomycin urgently demands alternative prevention 
and treatment strategies [161]. S. aureus frequently colonizes skin and mucosal 
membranes of the host without any clinical symptoms, but can suddenly erupt into a 
highly lethal invasive disease such as necrotizing pneumonia and IE in 
immunocompromised patients in hospital settings and even in healthy persons in the 
community [1, 162]. Efforts have been made to elucidate the mechanism of occurrence of 
highly lethal invasive disease by S. aureus in healthy community populations, but such 
mechanisms still remain elusive. 
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Staphylococcal enterotoxins (SEs), SE-like (SEl) toxins, and TSS toxin-1 (TSST-
1) are superantigens (SAgs). Most SAgs bind outside the peptide binding grooves of 
MHC II molecules on APCs and specific variable regions of TCR  chains (V) on T 
cells (SAg-reactive T cells) [163, 164]. Binding in this manner activates APCs and 
induces extensive TCR V-dependent proliferation of T cells, causing high level 
secretion of proinflammatory cytokines such as IL-1, IL-2, IFN-, and TNF- and 
immunomodulatory cytokines such as IL-10 and TGF- [165]. The initial expansion of T
 
cells is followed by activation-induced cell death or apoptosis, leading
 
to clonal deletion 
of SAg-reactive T cells [163, 166]. SAg-reactive T cells that escape from clonal deletion 
fail to proliferate and secrete IL-2. This phenomenon is often
 
referred to as anergy [167]. 
Thus far, 25 SAgs including SEA through SElX (except F) and TSST-1 have been 
characterized in S. aureus and most clinical isolates typically carry 5-7 different SAg 
genes [1, 144]. The causal link of SAgs in the pathogenesis of toxic shock syndrome and 
food poisoning, in which large amounts of SAgs (1-100 µg/ml) are produced, is well 
established [1, 168]. However, relatively small concentrations of SAgs (0.65 – 5 ng/ml) 
are produced in more frequently occurring asymptomatic colonization or chronic S. 
aureus infections [169-171], but the biological relevance of such small concentrations of 
SAgs in the pathogenesis of S. aureus is not fully understood. 
During infection, it is crucial to activate innate and adaptive immunity to control 
the pathogen, but it is equally important to regulate innate and adaptive immune 
responses to prevent tissue damage. Tregs have been recognized as a key component in 
the maintenance of immunological self-tolerance and the control of T cell immunity to 
prevent tissue damage by an extended proinflammatory response [172]. However, 
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immunosuppression by Tregs could be exploited by pathogens to promote infections 
[173, 174]. The Tregs can be broadly classified into CD4+ and CD8+ Tregs. CD4+ Tregs 
have been characterized as thymus-derived CD4+CD25+FOXP3+T cells (tTreg), and 
they can be induced by peripheral conversion of CD4+CD25- conventional T cells into 
CD4+CD25+FOXP3+T cells (pTreg) or in vitro-induced CD4+CD25+FOXP3+T cells 
(iTreg) by stimulation of peripheral blood mononuclear cells (PBMCs) via TCR using 
anti-CD3 mAb and anti-CD3/CD28 beads [172, 175-177].  
CD8+ Tregs were first described as CD8+ suppressor T cells from a mouse study 
in 1970 [23] showing the adaptive transfer of tolerance. Recently, CD8+ Treg studies 
have been rekindled because of the crucial roles of CD8+ Tregs in autoimmune disease 
and immunosuppression in transplant recipients. Several studies revealed various subsets 
of CD8+ Tregs. For example, in humans, repetitive stimulation of CD8+ T cells with 
allogeneic or xenogeneic APC induce CD8+CD28- T cells expressing immunoglobulin-
like transcript (ILT)-3 and ILT-4, which render tolerance in APC [117, 178]. 
Alloantigenic stimulation of CD8+ T cells with CD3 and CD28 mAbs induces 
CD8+CD103+ T cells, which suppress effector T cells by a cell-to-cell contact-dependent 
mechanism [179]. A recent study demonstrated that stimulation of human PBMCs with 
staphylococcal SAg (SEA and TSST-1) and streptococcal SAgs (SPEA, K/L) at a low 
concentration (1 ng/ml) induced CD8+CD25+FOXP3+ T cells with suppressive activity 
mediated by an unknown cell-to-cell dependent mechanism [119]. In line with these 
findings, our previous study demonstrated that stimulation of bovine PBMCs with SEC1 
at a concentration resulting in suboptimal T cell proliferation (1-5 ng/ml) induced 
immunosuppressive CD4+CD25+ and CD8+CD25+ Tregs [170]. These results suggest 
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that the strength of TCR signaling determined by the concentration of SAg might 
differentially regulate phenotypic and functional characteristics of immunosuppressive T 
cells.  
In this study, we determined the phenotypic and functional characteristics of 
human CD8+CD25+ T cells induced by stimulation of human PBMCs with SEC1 at 
concentrations inducing optimal (1 μg/ml) and suboptimal (1 ng/ml) stimulation. Our 
results demonstrated that despite similar expression of phenotypic and functional Treg 
markers in CD8+CD25+FOXP3+ T cells induced from both optimal and suboptimal 
stimulation, suppressive activity was only observed in CD8+CD25+FOXP3+ T cells 
induced from suboptimal stimulation. These results suggest that a low concentration of 
SAg produced during asymptomatic colonization or chronic S. aureus infection induces 
immunosuppressive CD8+ Tregs that may trigger outbreaks of highly lethal invasive S. 
aureus infections in healthy community populations as well as immunocompromised 
hospital patients. 
2.3 Materials and methods 
2.3.1 PBMC isolation 
Healthy volunteers aged 18-40 y of age were recruited into the study. The 
protocol (13-191) was reviewed and approved by the institutional review board at 
Mississippi State University, and a written informed consent form was obtained from all 
volunteers. Blood was obtained by venipuncture, and peripheral blood mononuclear cells 
(PBMCs) were isolated by gradient centrifugation using Histopauqe-1077 (Sigma-
Aldrich, St. Louis, MO). The isolated PBMCs were resuspended in RPMI 1640 medium 
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containing 10% heat-inactivated FBS, 2 mM L-glutamine and 1% penicillin-streptomycin 
(Invitrogen, Carlsbad, CA).  
2.3.2 Purification of SEC1 
Dr. Scott Minnich (University of Idaho) kindly provided staphylococcal 
enterotoxin C1 (SEC1) which was purified from S. aureus RN4220 (pMIN121) using 
preparative isoelectric focusing with a broad isoelectric point (3 to 10) and a narrow 
isoelectric point (6 to 8) range of ampholytes in succession [180]. 
2.3.3 Cell stimulation  
To determine T cell proliferation in response to SEC1, human PBMCs were 
adjusted to 5 × 10
5
 cells per well in a 96-well plate with the indicated concentrations of 
SEC1 (0.001-10,000 ng/ml). Cells were incubated at 37°C in 5% CO2 for 72 hours. Cells 
were pulsed with 1 μCi of [
3
H]-thymidine for 18 hours. Cellular DNA was harvested on 
glass fiber filters, and incorporation of [
3
H]-thymidine into cellular DNA was quantified 
by liquid scintillation counting. For phenotypic and functional assay, CD25+ cells were 
depleted from the PBMCs using CD25 microbeads (Miltenyi Biotec, San Diego, CA) to 
prevent expansion of preexisting Tregs (CD4+CD25+ and CD8+CD25+ T cells) and their 
influence on induction of Tregs by SEC1. The PBMCs depleted of CD25+ cells 
(PBMC/CD25-) were adjusted to 1.5 × 10
6
 cells per well in 6-well plates and stimulated 
with SEC1 at optimal (1 μg/ml) or suboptimal (1 ng/ml) stimulation conditions for the 
indicated times.  
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2.3.4 Immunophenotyping and flow cytometry 
For phenotypic characterization of CD8+CD25+ T cells induced by SEC1 
stimulation, mAbs specific to human CD8-FITC, CD25-PECy7, CTLA-4-
allophycocyanin, IL-10- allophycocyanin, and IFN-γ- allophycocyanin were purchased 
from BD Biosciences (San Jose, CA). Antibodies specific for human TCR Vβ2-PE and 
TCR Vβ14-PE were purchased from Beckman Coulter (Brea, CA). MAbs specific for 
human CD28-PE, CD127- allophycocyanin, FOXP3- allophycocyanin, GITR-PE, HLA-
DR-PE, OX40-PE, and TNFR2-PE as well as Brefeldin A were purchased from 
eBioscience (San Diego, CA). Mab specific for anti-TGF-β- allophycocyanin was 
purchased from R&D Systems (Minneapolis, MN). For neutralization assays, anti-human 
IL-10, TGF-β, IFN-γ, and isotype controls for rat-IgG1 and mouse-IgG1 were purchased 
from eBioscience. To measure cytokine secretion, culture supernatants from suboptimal 
stimulation with SEC1 were harvested every 2 days and analyzed by a Milliplex 34-plex 
human cytokine Luminex kit (Millipore) according to the manufacturer’s instruction.  
For surface staining, cells were harvested, washed with FACS buffer 
(eBioscience), and stained for 30 min on ice with different combinations of mAbs 
specific for human CD8-FITC, CD25-PECy7, CD28-PE, CD127- allophycocyanin, 
GITR-PE, HLA-DR-PE, OX40-PE, TNFR2-PE, TCR Vβ2-PE, or TCR Vβ14-PE. For 
intracellular staining, cells were incubated with Brefeldin A for 1 hour under previously 
described culture conditions, followed by surface staining, and then further fixed and 
permeabilized with the Human FOXP3 Buffer Set (eBioscience) according to the 
manufacturer’s instructions. Fixed/permeabilized cells were stained with mAbs specific 
for human FOXP3- allophycocyanin, TGF-β- allophycocyanin, CTLA-4- 
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allophycocyanin, IL-10- allophycocyanin, or IFN-γ- allophycocyanin. Cells were washed 
with FACS buffer and analyzed using a FACSAria III flow cytometer (BD Biosciences). 
Data were analyzed using FlowJo software (Tree Star, Ashland, OR). Fluorescence minus 
one (FMO) controls or isotype controls were used to ensure that the upregulation was not 
due to a non-specific Ab effect. 
2.3.5 Autologous mixed leukocyte reaction (MLR) 
For functional assays, CD8+CD25+ or CD8+CD25- T cells were purified by 
negative selection with a CD8+ T cell isolation kit II, followed by anti-CD25 magnetic 
beads (Miltenyi Biotec) according to the manufacturer’s instructions. For some assays, 
naïve CD4+CD25- T cells and CD14+ cells were purified from unstimulated PBMCs 
using a naïve CD4+ T cell purification kit and a monocyte purification kit, respectively 
(Miltenyi Biotec). The purity of isolated cells was routinely monitored by flow 
cytometry, and was consistently over 95-99% (data not shown).  
Naïve CD4+CD25- T cells were labeled with 2.5 µM CFSE (Invitrogen, 
Carlsbad, CA) for 5 min at 37 
o
C and were washed with warm RPMI 1640 medium. 
CFSE-labeled naïve CD4+CD25- T cells (1 × 10
5
 cells per well, responder cells) were 
mixed with various numbers (1 × 10
5
, 5 × 10
4
, 1 × 10
4
) of CD8+CD25+ T cells induced 
from suboptimal and optimal stimulation with SEC1 for 6 and 4 days, respectively. Cells 
were stimulated with anti-CD3/CD28 beads at a 1:1 bead to cell ratio. After 4 days, cells 
were labeled with CD4-PE to separate the CFSE-labeled CD4+ T cells from 
CD8+CD25+ T cells induced by SEC1 stimulation. Proliferation of CD4+ T cells was 
determined as the dilution of CFSE signal using flow cytometry. For the contact 
dependent suppression assay, CD8+CD25 T cells induced from suboptimal stimulation 
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with SEC1were treated with 10 µM of mitomycin C (Sigma-Aldrich) for 2 hours to 
prevent protein synthesis and proliferation [181, 182]. After thorough washing, 
mitomycin C-treated CD8+CD25+ T cells were mixed with CFSE labeled responder cells 
and stimulated with anti-CD3/CD28 beads as described above. For the soluble factor 
dependent suppression assay, CD8+CD25+ T cells induced by suboptimal stimulation 
with SEC1 were added to the upper chamber of a transwell (0.45 μM pore size, Corning 
Life Sciences, Tewksbury, MA) and an equal number of CFSE labeled responder cells 
were added to the bottom chamber of a transwell. Cells were stimulated as described 
above.  
In some experiments, mAbs (10 µg/ml) specific for CTLA-4 (eBioscience), IL-10 
(R&D systems), TGF-β (R&D systems), IFN-γ (eBioscience), or Gal1 (Santa Cruz, 
Dallas, TX), or the same quantify of isotype controls (eBioscience) were added to cells. 
In addition, ZM241385 (10 µM, adenosine 2A antagonist, Tocris, Minneapolis, MN), 
indomethacin (25 µM, COX inhibitor, Sigma-Aldrich), or 3,4-dichloroisocumarin (50 
µM, DCI, serine protease inhibitor, EMD Millipore, Billerica, MA) were added to the 
autologous MLR assay as indicated in the results.  
2.3.6 Immunoblotting 
To determine activation of CD8+ T cells by SEC1 via signaling through TCR, we 
determined the phosphorylation of CD3ζ. CD8+CD25- T cells (5 × 10
5
) that were 
purified and stimulated with 1 ng/ml of SEC1 for 10 minutes in the presence or absence 
of CD14+ monocytes (4 ×10
5
). Whole cell lysates were separated by 12.5% SDS-PAGE 
and transferred to a PVDF membrane. The phosphorylation of CD3ζ was detected by 
anti-CD3ζ (phosphoryl Y142) Ab (Abcam, Cambridge, MA), followed by HRP-
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conjugated sheep anti-mouse IgG (GE Healthcare). The loading control was assessed by 
immunoblot against β-actin using anti-β actin Ab (Sigma-Aldrich), followed by HRP-
conjugated donkey anti-rabbit IgG (GE Healthcare).  
2.3.7 Quantification of selective expansion of TCR Vβ using real-time PCR. 
Total RNA was prepared from samples taken before and after stimulation of 
CD8+CD25- T cells with SEC1 (1 ng/ml) for 4 days and cDNA was synthesized using a 
cDNA synthesis kit (Invitrogen). Selective expansion of TCR Vβ was assessed by 
quantitative real-time PCR using an ABI Prism 7500 real-time PCR system (Applied 
Biosystems, Foster City, CA) as described previously (29). 
2.3.8 Statistical analysis 
Data were obtained from 3 separate experiments for each of 2 or 3 donors 
generating 6 or 9 independent experiments. Statistical significance among different 
treatment groups was analyzed with the one-way analysis of variance (ANOVA), 
followed by Tukey’s HSD for post hoc test using GraphPad Prism software (Version 
7.0.3. La Jolla, CA). Differences with p value < 0.001 were considered statistically 
significant. 
2.4 Results 
2.4.1 Stimulation of human PBMCs by SEC1 induced expression of FOXP3 in 
CD8+ T cells  
We first measured human T cell proliferation in response to a serial dilution of 
SEC1 to determine the concentrations of SEC1 needed to induce maximal and half 
maximal T cell proliferation to set as the optimal and suboptimal stimulation conditions, 
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respectively. As expected, the T cell proliferation response was positively related to the 
concentration of SEC1 (Fig. 2.1A). Maximal T cell proliferation was observed at 1 μg/ml 
and approximately half maximal T cell proliferation was observed at 1 ng/ml. The 
decreased proliferation observed at 10 μg/ml was likely due to the depletion of culture 
medium components resulting from vigorous proliferation. Based on these results, we 
defined the concentration of SEC1 that induced optimal and suboptimal stimulation as 1 
μg/ml and 1 ng/ml, respectively.  
 
Figure 2.1 Concentration-dependent expression kinetics of FOXP3 in CD8+CD25+ T 
cells by SEC1. 
(A) Human T cell proliferation after exposure to SEC1 for 4 days was measured by the incorporation of 
[
3
H]-thymidine. The data shown are the mean ± SEM of nine independent experiments (three separate 
experiments for each of three different donors). (B) Human PBMCs were stimulated with various 
concentrations of SEC1 for 4 days, and expression of CD25 and FOXP3 in CD8+ T cells was measured by 
flow cytometry. The data shown are from a single representative experiment. (C) The data shown are the 
mean percentage ± SEM of CD8+CD25+FOXP3+ T cell combined from nine independent experiments. 
To examine the kinetics of SEC1 concentration-dependent changes in expression 
of FOXP3 in human CD8+CD25+ T cells, human PBMC depleted of CD25+ cells 
(PBMC/CD25-) were stimulated with various concentrations of SEC1 ranging from 0.01 
ng/ml to 1 μg/ml for 4 days. The CD25+ T cells were depleted to prevent expansion of 
preexisting regulatory cells commonly expressing CD25. Expression of FOXP3 in 
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CD8+CD25+ T cells was positively related to the concentration of SEC1. Expression of 
FOXP3 in CD8+CD25+ T cells was the highest at 1 µg/ml and gradually decreased with 
lower concentrations of SEC1 (Fig. 2.1B and C). To examine the kinetics of expression 
of FOXP3 in CD8+CD25+ T cells, human PBMC/CD25- cells were stimulated with 
SEC1 under optimal (1 μg/ml) and suboptimal (1 ng/ml) stimulation conditions up to 8 
days. Under the optimal stimulation condition, expression of FOXP3 in CD8+CD25+ T 
cells rapidly increased and peaked at day 4 post stimulation (62.4%±11.5), then gradually 
decreased thereafter (Fig. 2.2A and B, optimal panel). On the contrary, under the 
suboptimal stimulation condition, expression of FOXP3 in CD8+CD25+ T cells was 
delayed but gradually increased to reach 54.35%±6.5 at day 8 post stimulation (Fig. 2.2A 




Figure 2.2 Time-dependent expression kinetics of FOXP3 in CD8+CD25+ T cells by 
induced by stimulation with SEC1. 
Human PBMCs were stimulated with an optimal (1 µg/ml) and a suboptimal stimulation condition (1 
ng/ml) of SEC1 up to 8 days. Expression of CD25 and FOXP3 in CD8 T cells was measured using flow 
cytometry. (A) Data shown are a single representative experiment gated on CD8+ T cells. (B) Data shown 
are the mean percentage ± SEM of CD8+CD25+FOXP3+ T cell combined from nine independent 
experiments measured from three different donors. 
2.4.2 CD8+CD25+ T cells induced from the suboptimal, but not optimal, SEC1 
stimulation condition were functionally immunosuppressive 
To determine functional characteristics of CD8+CD25+ T cells induced from 
optimal and suboptimal stimulation with SEC1, we conducted autologous mixed 
leukocyte reaction (MLR). The PBMC depleted of CD25+ cells were stimulated with 1 
µg/ml (optimal stimulation) or 1 ng/ml (suboptimal stimulation) of SEC1 for 4 days or 6 
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days at which FOXP3 was highly expressed in CD8+CD25+ T cells. Purified 
CD8+CD25+ T cells were co-cultured with freshly prepared autologous CFSE-labeled 
naïve CD4+CD25- T cells (responder cells) in the presence of anti-CD3/CD28 beads as T 
cell stimulants. To separate the responder cells from CD8+CD25+ T cells, cells were 
stained with CD4-PE and CD4+ T cells were gated as depicted in Appendix Fig. 1. As 
expected, anti-CD3/CD28 beads induced proliferation of naïve CD4+CD25- T cells (Fig. 
2.3A). Proliferation of naïve CD4+CD25- T cells was significantly inhibited by 
CD8+CD25+ T cells induced by suboptimal stimulation with SEC1. The suppression was 
positively related to the number of CD8+CD25+ T cells induced from suboptimal 
stimulation with SEC1 (Fig. 2.3B and E). By contrast, CD8+CD25+ T cells induced from 
optimal stimulation with SEC1 slightly increased proliferation of naïve CD4+CD25- T 
cells (Fig. 2.3C and E). In the absence of anti-CD3/CD28 beads, CD8+CD25+ T cells 
induced by optimal stimulation with SEC1 did not induce proliferation of naïve 
CD4+CD25- T cells indicating there was no SEC1 contamination in CD8+CD25+ T cells 
purified after stimulation with SEC1 (Fig. 2.3C). Together these results demonstrate that 
CD8+CD25+ T cells induced by suboptimal stimulation with SEC1, but not optimal 




Figure 2.3 Suppression of naïve CD4+CD25- T cell proliferation by CD8+CD25+ T 
cells induced from a suboptimal stimulation with SEC1, not from an 
optimal stimulation. 
(A) Naïve CD4+CD25- T cells were purified, labeled with CFSE, and stimulated anti-CD3/CD28 beads for 
4 days. Proliferation of CD4+ T cells were analyzed by quantifying the dilution of CFSE signal measured 
by flow cytometry. (B) CD8+CD25+ T cells induced from suboptimal stimulation with SEC1 for 6 days 
were purified and co-cultured with CFSE-labeled CD4+CD25- T cells at various ratios for 4 days in the 
absence or presence of anti-CD3/CD28 beads. (C). CD8+CD25+ T cells induced from optimal stimulation 
with SEC1 for 4 days were purified and co-cultured with CFSE-labeled CD4+CD25- T cells for 4 days in 
the absence or presence of anti-CD3/CD28 beads. (E) The data shown are the mean ± SEM of non-
proliferating CD4+ T cells combined from nine independent experiments measured from three different 
donors. Different letters indicate significant differences in the mean percentage between treatments 




Figure 2.4 Suppression by CD8+CD25+ T cells induced from suboptimal stimulation 
with SEC1 is mediated by the cell-to-cell contact dependent manner to a 
larger extent than the soluble factor-dependent manner. 
CFSE-labeled naive CD4+ T cells were co-cultured with an equal number of CD8+CD25+ T cells induced 
from suboptimal stimulation with SEC1 fixed with mitomycin C for a contact-dependent suppression assay 
or with CD8+CD25+ T cells in the top chamber of Transwell for a soluble factor-dependent suppression 
assay. Cells were stimulated with anit-CD3/CD28 beads and proliferation of CD4+ T cells were analyzed 
by flow cytometry. (A) Data shown are a single representative result of CFSE dilution histograms. (B) Data 
shown are the mean percentage ± SEM of non-proliferating CD4+ T cells combined from nine independent 
experiments measured from three different donors. Different letters indicate significant differences in the 
mean percentage between treatments determined by ANOVA followed by Tukey’s HSD test (p < 0.001). 
To investigate whether the suppressive activity of CD8+CD25+ T cells induced 
by suboptimal stimulation with SEC1 is mediated by cell-to-cell contact or soluble 
factors, we conducted autologous MLR using mitomycin C-treated CD8+CD25+ T cells 
to prevent de novo T cell activation or in a transwell to prevent direct cell-to-cell contact, 
but allow migration of soluble factors (for soluble factor-dependent suppression). The 
mitomycin C-treated CD8+CD25+ T cells completely inhibited proliferation of naïve 
CD4+CD25- T cells in response to anti-CD3/CD28 beads (Fig. 2.4). On the contrary, 
CD8+CD25+ T cells in a transwell partially inhibited proliferation of naïve CD4+CD25- 
T cells in response to anti-CD3/CD28 beads (Fig.2.4). These results suggest that the 
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suppressive activity by CD8+CD25+ T cells induced by suboptimal stimulation with 
SEC1 is mediated predominantly by cell-to-cell contact, but also involves soluble factors. 
2.4.3 CD8+CD25+FOXP3+ T cells induced by suboptimal stimulation with 
SEC1 expressed surface makers and cytokines related to regulatory cells 
To characterize the phenotype of CD8+CD25+ T cells induced from suboptimal 
stimulation with SEC1 for 6 days, cellular markers related to Tregs were evaluated using 
flow cytometry. Before stimulation, naïve CD8+ T cells did not express classical Treg 
markers such as CD25, CTLA-4, GITR, OX-40, TNFR2, and CD45RO (Appendix Fig. 
2A). After suboptimal stimulation, CD8+CD25+ cells highly expressed CD25, CD28, 
HLA-DR, CTLA-4, TNFR2, and CD45RO but expression of CD127, GITR, and OX40 
decreased or slightly increased (Appendix Fig. 2A). To further analyze the phenotype of 
CD8+CD25+FOXP3+ T cells, analysis was performed by gating on CD8+CD25+ T 
cells. The CD8+CD25+FOXP3+ T cells highly expressed CD28, CD45RO, CTLA-4, 
HLA-DR, and TNFR2, and less than 20% of CD8+CD25+FOXP3+ T cells expressed 
CD127, GITR, and OX40 (Fig. 2.5A and Appendix Fig. 2B). It is noteworthy that CTLA-
4 was only detected by intracellular staining, but not by surface staining. The 
CD8+CD25+ T cells induced from optimal stimulation with SEC1 showed similar 
phenotypes with the exception of higher expression of GITR and OX40 compared to 




Figure 2.5 Expression of cell surface markers and cytokines related to Tregs by 
CD8+CD25+ T cells induced from suboptimal stimulation with SEC1. 
Human PBMC depleted of CD25+ T cells were stimulated with a suboptimal stimulation concentration of 
SEC1 (1 ng/ml) for 6 days. Expression of surface markers and cytokines related to related to Tregs were 
measured by flow cytometry and a Luminex ELISA kit. (A) Data shown are the mean percentage ± SEM of 
CD8+CD25+FOXP3+ T cells expressing surface markers related to Tregs combined from nine independent 
experiments measured from three different donors. Expression of CTLA-4 was measured by the 
intracellular staining. (B) Data shown are the mean percentage ± SEM of CD8+CD25+ T cells expressing 
cytokines related to Tregs measured by intracellular staining and flow cytometry. Data are combined from 
nine independent experiments measured from three different donors. (C) During suboptimal stimulation 
with SEC1, the culture supernatant was collected every 2 days and analyzed by a Milliplex Luminex 
cytokine analysis kit. Data shown are combined results from six independent experiments measured from 
two different donors. 
To determine the functional characteristics of CD8+CD25+ T cells induced by 
suboptimal stimulation with SEC1, expression of cytokines related to regulatory 
functions such as IL-2, IL-10, TGF-β, and IFN-γ were analyzed using flow cytometry and 
a Milliplex Luminex cytokine analysis kit. Before stimulation, minimal expression of IL-
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2, IL-10, TGF-β, and IFN-γ in CD8+ T cells was detected (Fig. 2.5B). Upon suboptimal 
stimulation, IL-2 gradually increased and peaked at day 4, then gradually decreased at 
day 6. Expression of IL-10, TGF-β, and IFN-γ gradually increased by day 6 and was 
sustained. Notably, a decrease of IL-2 expression at 6 days (Fig. 2.5B) was concurrent 
with an increase of FOXP3 expression (Fig. 2.2), which is a known transcriptional 
repressor of the IL-2 promoter. Similar patterns of cytokine secretion in the culture media 
was observed using a Milliplex Luminex cytokine analysis kit (Fig. 2.5C). Taken 
together, the characteristics of CD8+CD25+FOXP3+ T cells induced from suboptimal 
stimulation with SEC1 was CD28+, CTLA4+, TNFR2+, CD45RO+, HLA-DR+, 
secreting IL-10, TGF-β, and IFN-γ. 
2.4.4 Immunosuppression of CD8+ Treg induced from suboptimal stimulation 
with SEC1 was mediated by galectin-1 and granzymes 
Previous studies demonstrated that immunosuppression by CD4+ and CD8+ 
Tregs is mediated by CTLA-4, IL-10, TGF-β, and IFN-γ via membrane bound receptors 
or direct interaction with APC and CD4+ T cells [172, 178, 179, 183, 184]. Since 
expression of these molecules was highly increased in CD8+CD25+ T cells induced by 
suboptimal stimulation with SEC1, we sought to determine their role in 
immunosuppression using neutralizing mAbs. The blockade of CTLA-4, IL-10, TGF-β, 
and IFN-γ using mAb failed to inhibit the suppressive activity of CD8+CD25+ T cells 
induced from suboptimal stimulation with SEC1 (Fig. 2.6). Various combinations of 





Figure 2.6 Suppression by CD8+CD25+ T cells induced by suboptimal stimulation 
with SEC1 was not dependent on CTLA-4, TGF-β, IL-10, IFN-, CTLA-4, 
cAMP, and COX. 
CFSE-labeled naïve CD4+CD25- T cells (110
5
) were co-cultured with an equal number of CD8+CD25+ 
T cells induced from suboptimal stimulation with SEC1 in the presence of anti-CD3/CD28 beads and mAb 
(10 µg/ml) neutralizing CTLA-4, TGF-, IL-10, IFN-, Indomethacin (25 µM, COX inhibitor), ZM241385 
(10 µM, adenosine 2A antagonist) for 4 days. Proliferation of CD4+ T cells were analyzed by flow 
cytometry. Data shown are a single representative CFSE dilution histograms from nine independent 
experiments measured from three different donors. 
Adenosine released by Tregs triggers accumulation of intracellular cAMP which 
induces the transcriptional factor ICER (inducible cAMP early repressor), resulting in 
suppression of T cells [185]. The blockade of adenosine receptor 2A by the small 
molecule inhibitor, ZM241385 [186], with an increasing dose up to 10 µM did not affect 
the suppressive activity of CD8+CD25+ T cells induced from suboptimal stimulation 
(data with 10 µM are shown in Fig. 6). A previous study showed that CD4+CD25+ Tregs 
express cyclooxygenase-2 and produce prostaglandin E2 which suppresses T cell immune 
responses by eliciting cAMP mediated immune suppression (34). However, the inhibition 
of COX by indomethacin with an increasing dose up to 25 µM did not affect the 
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suppressive activity of CD8+CD25+ T cells either (data with 25 µM are shown in Fig. 
2.6). 
 
Figure 2.7 Expression of galectin-1 and granzymes by CD8+CD25+ T cells induced 
from optimal and suboptimal stimulation with SEC1. 
(A) Human PBMC depleted of CD25+ T cells were stimulated with an optimal (1 µg/ml) and suboptimal 
stimulation concentration of SEC1 (1 ng/ml) for 4 and 6 days, respectively. Intracellular and surface 
expression of galectin-1 and intracellular expression of granzyme A and B was analyzed by flow 
cytometry. Data shown are a single representative dot plots gated on CD8+CD25+ T cells. (B) Data shown 
are the mean percentage ± SEM of CD8+CD25+FOXP3+ T cells expressing galectin-1, granzyme A and B 
combined from nine independent experiments measured from three different donors. 
In an effort to elucidate phenotypic and functional markers of CD8+ Tregs, we 
performed transcriptomic and proteomic analyses and found that galectin-1 and granzyme 
A and B were consistently upregulated in CD8+CD25+ T cells induced by suboptimal 
stimulation with SEC1. To confirm the transcriptomic and proteomic analysis results, we 
measured expression of galectin-1 and granzymes in CD8+CD25+ T cells using flow 
cytometry. In both optimal and suboptimal stimulation conditions, galectin-1 was 
predominantly detected by intracellular staining, not by surface staining (Fig. 2.7A and 
B). Similarly, granzyme A and B were highly expressed intracellularly in CD8+CD25+ T 
cells (Fig. 2.7A and B). Finally, the blockade of galectin-1 with an anti-Gal-1 mAb or 
granzymes with a serine protease inhibitor (DCI, 3,4-dichloroisocumarin) partially 
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attenuated the suppressive activity of CD8+CD25+ T cells induced by suboptimal 
stimulation, restoring approximately 50% of proliferation as compared to the naïve CD4+ 
T cell control (Fig. 2.8). Combined treatment with DCI and anti-Gal1 restored 
approximately 75% of native T cell proliferation (Fig. 2.8). Furthermore, addition of anti-
Gal-1 mAb to autologous MLR using mitomycin C-treated CD8+CD25+ T cells fully 
inhibited suppressive activity. In contrast, an addition of anti-Gal-1 mAb to autologous 
MLR in transwell did not inhibit the suppressive activity. These results strongly suggest 
that galectin-1 is largely responsible for the contact-dependent-suppression by 
CD8+CD25+ T cells induced from suboptimal stimulation with SEC1. Granzymes are 
well known soluble factors produced by cytotoxic CD8+ T cell and induce apoptosis in 
target cells [187]. Addition of DCI, a serine protease inhibitor, to the autologous MLR in 
the transwell fully inhibited the suppressive activity of CD8+ Treg. These results suggest 
that granzymes are responsible for the soluble factor-dependent suppression by 




Figure 2.8 The suppressive activity of CD8+CD25+ T cells induced from suboptimal 
stimulation with SEC1 is mediated by galectin-1 and granzymes. 
CFSE-labeled naïve CD4+CD25- T cells (110
5
) were co-cultured with an equal number of CD8+CD25+ 
T cells induced from suboptimal stimulation with SEC1 in the presence of anti-CD3/CD28 beads and a 
mAb (10 µg/ml) neutralizing galectin-1 and/or 3,4-dichloroisocumarin (50 µM, DCI, serine protease 
inhibitor) for 4 days. In some experiments, CD8+CD25+ T cells induced from suboptimal stimulation with 
SEC1 were added to the top chamber of the Transwell or were fixed with mitomycin C and added to the co-
culture. Proliferation of CD4+ T cells were analyzed by flow cytometry. (A) Data shown are a single 
representative CFSE dilution histograms. (B) Data shown are the mean percentage ± SEM of non-
proliferating CD4+ T cells combined from nine independent experiments measured from three different 
donors. Different letters indicate significant differences in the mean percentage between treatments 
determined by ANOVA followed by Tukey’s HSD test (p< 0.001). 
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2.4.5 Induction of CD8+CD25+FOXP3 T cells by a suboptimal stimulation with 
SEC1 is APC-restricted and TCR-Vβ dependent manner 
 
Figure 2.9 Induction of CD8+CD25+FOXP3 T cells by SEC1 is APC-restricted and 
TCR V-dependent. CD8+CD25- T cells were purified from human 
PBMCs and stimulated with SEC1 (1 ng/ml) in the presence or absence of 
CD14+ cells. 
(A) After 6 days stimulation, expression of CD25 and FOXP3 was measured using flow cytometry. Data 
shown are representative results from nine independent experiments measured from three different donors. 
(B) After stimulation with SEC1 (1 ng/ml) for 10 min, cells were lyzed and cell lysates were analyzed by 
immunoblotting using mAb specific to phosphorylated CD3ζ as an indication of T cell activation via TCR. 
The level of β-actin was used as loading controls. (C) After 4 days stimulation with SEC1 (1 ng/ml), the 
selective expansion of TCR Vβ was measured by quantitative real time PCR. Data shown are the mean ± 
SEM of six independent measurements from two donors. (D) Expression of TCR Vβ14 in 
CD8+CD25+FOXP3+ T cells was measured by flow cytometry. Data shown are the mean percentage of 
CD8+CD25+Vβ14+ T cells combined from six independent measurements from two donors. (E) 
CD8+CD25+ T cells were induced by stimulation of purified CD8+CD25- T cells with SEC (1ng/ml) in the 
presence of CD14+ cells. Purified CD8+CD25+ T cells were co-cultured as described in Fig. 3. Data 
shown are a single representative CFSE dilution histograms from nine independent experiments measured 
from three different donors. 
Although it is well documented that CD4+ T cells are activated by SAgs that 
directly bind to specific V segments of TCR on CD4+ T cells and MHC II on APC 
[188], the exact mechanism by which CD8+ T cells are activated by SAgs is not clearly 
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understood. For instance, it is possible that induction of CD8+CD25+FOXP3 T cells by 
SEC1 might be due to a direct activation of CD8+ T cells by SEC1 or by an indirect 
effect following activation of CD4+ T cells by SEC1. To address these questions, naïve 
CD8+CD25- T cells were purified from human PBMCs and stimulated with SEC1 at the 
suboptimal stimulation condition in the presence or absence of APC (CD14+ cells). In 
the presence of APC, SEC1 induced expression of CD25 and FOXP3 in CD8+ T cells 
(Fig. 2.9A). In contrast, in the absence of APC, SEC1 was unable to induce expression of 
CD25 and FOXP3 in CD8+ T cells (Fig. 2.9A). These results indicated that activation of 
CD8+ T cells by SEC1 requires the presence of APC. To determine whether activation of 
CD8+ T cells by SEC1 is initiated through the TCR signaling pathway, CD8+ T cells 
were incubated with SEC1 for 10 min and the phosphorylation of ITAMs in the CD3ζ 
chain, the initial event in the TCR signaling cascade, was measured by Western blot. The 
phosphorylation of the CD3ζ chain was detected from CD8+ T cells activated with SEC1 
in the presence of APC, not in the absence of APC (Fig. 2.9B). To determine whether 
activation of CD8+ T cells by SEC1 is also TCR Vβ-dependent, the distribution of the 
TCR Vβ repertoire in CD8+ T cells before and after stimulation with SEC1 was 
measured using quantitative real time PCR. Results showed that selective expansion of 
CD8+ T cells bearing TCR Vβ 3, 12, 13.2, 14, 15, 17, and 20 occurred (Fig. 2.9C). These 
results were identical to those previously observed with CD4+ T cells [148]. Flow 
cytometry results further confirmed the quantitative real time PCR results showing an 
increase of Vβ 14 after stimulation with SEC1 (Fig. 2.9D). Lastly, CD8+CD25+ T cells 
induced by suboptimal stimulation with SEC1 in the absence of CD4+ T cells were able 
to suppress proliferation of responder cells (Fig. 2.9E), indicating induction of CD8+ 
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Tregs by suboptimal stimulation with SEC1 is independent from CD4+ T cells. Together, 
these results suggest that SEC1 directly activates CD8+ T cells via the TCR signaling 
pathway in an APC restricted- and TCR Vβ-dependent manner, similar to the mechanism 
documented in CD4+ T cells. The results also demonstrate that suboptimal stimulation 
induces expansion of immunosuppressive CD8+CD25+FOXP3+ T cells. 
2.5 Discussion 
It has long been postulated that staphylococcal SAgs contribute to the 
pathogenesis of S. aureus since they are potent immune modulators. However, while 
toxic shock syndrome caused by exposure to high concentrations of SAgs (1-100 µg) are 
well documented, relatively little is known about the effect of low concentrations of SAgs 
(1-10 ng) associated with more frequent types of asymptomatic mucosal colonization or 
chronic infections by S. aureus. A recent study demonstrated that stimulation of human 
PBMCs with SAgs at a concentration of 1 ng/ml induced immunosuppressive 
CD8+CD25+FOXP3+ T cells [119]. However, the mechanism of suppression still 
remains elusive and the functional characteristics of CD8+CD25+FOXP3 induced by 
stimulation with a higher concentration of SAgs have not been tested. In this study, we 
demonstrated, for the first time to our knowledge, that the concentration of SAgs 
markedly influences the functional characteristics of CD8+ T cells. Specifically, 
suboptimal stimulation by SAg induces functionally immunosuppressive CD8+ 
regulatory T cells, whereas an optimal stimulation by SAg induces expression of 
phenotypic markers of CD8+ regulatory T cells, but these cells are not functionally 
immunosuppressive. We further determined that immunosuppression by CD8+CD25+ T 
cells induced by suboptimal stimulation with SEC1 was mediated primarily by galectin-1 
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and granzymes in a contact-dependent and soluble factor-dependent manner, 
respectively. Our results suggest that exposure to a higher concentration of SAg induces 
T cell activation without development of Tregs leading to uncontrolled inflammation, 
likely contributing to conditions such as toxic shock syndrome. Our results further 
suggest that exposure to lower concentrations of SAg induces T cell activation leading to 
development of Tregs, resulting in immune suppression. Together these results 
demonstrate that SAgs can induce completely opposite immune responses (i.e., toxic 
shock syndrome versus immune suppression) depending on the concentration of SAg 
presented to the host immune system. 
A limitation in investigating Tregs in humans is continued identification of, and 
debate about, specific markers. Although FOXP3 has an essential role in development of 
Tregs, as demonstrated in this study and others, FOXP3 may not be a reliable marker for 
Tregs especially in humans since T cell activation via TCR transiently induces expression 
of FOXP3 in both CD4+ and CD8+ T cells [122, 123]. In line with others’ findings, our 
results showed that CD8+CD25+ T cells induced by optimal stimulation with SEC1 also 
highly expressed FOXP3 but were not immunosuppressive. Thus, expression of FOXP3 
is necessary for the development of Tregs, but not sufficient to define Tregs.  
Induction and development of FOXP3+ Tregs require synergistic interaction of 
cellular signaling pathways. They include suboptimal stimulation through TCR/MHC II 
without CD28/CD86 costimulatory signals or with inhibitory signals by CTLA-4. These 
signaling cascades lead to inactivation of PI3K-AKT-mTOR (phosphatidylinositol 3-
kinase-AKT-mammalian target of rapamycin) pathways, while activation of inhibitory 
cytokine pathways, such as TGF-/TGF- receptor and TNF-/TNF receptor superfamily 
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[189-191]. In this study, the phenotypes and cytokines produced by 
CD8+CD25+FOXP3+ T cells induced by suboptimal stimulation with SEC1 were 
CD28+, CTLA4+, TNFR2+, CD45RO+, HLA-DR+, IL-2+, IL-10+, IFN-+, and TGF-
+, which satisfied several conditions to induce FOXP3+ Tregs, i) suboptimal 
stimulation through TCR/MHC II, ii) induction of CTLA-4 expression, and iii) induction 
of TGF- and IL-10 expression. However, it is noteworthy that the non-
immunosuppressive CD8+CD25+FOXP3+ T cells induced from optimal stimulation with 
SEC1 also showed similar phenotypes and cytokines to those observed with the 
immunosuppressive CD8+CD25+ T cells induced by suboptimal stimulation. A recent 
study demonstrated that stimulation of T cells in the presence of IL-2 and TNF receptor 
superfamily ligands (GITR-L, OX40-L, 4-1BB-L, and TNF) induced higher expression 
of FOXP3 than stimulation without those ligands. This would explain higher expression 
of FOXP3 in CD8+CD25+ T cells induced by optimal stimulation in which GITR and 
OX40, and TNFR2 were more highly expressed than with suboptimal stimulation. 
However, functional maturation of Treg may require additional signals. The CD28 
molecule, highly expressed in CD8+CD25+ T cells induced by both suboptimal and 
optimal stimulation conditions, may contribute to the functional maturation of FOXP3+ T 
cells differently. Previous studies demonstrated that a co-stimulation signal through 
CD28 is required for tTreg development by inducing expression of TNF receptor 
superfamily members. However, strong co-stimulation through CD28 suppressed the 
differentiation of pTreg or iTreg. Importantly, a recent study demonstrated that SAg can 
directly interact with CD28, which is essential to elicit an inflammatory cytokine storm in 
toxic shock syndrome [192]. It is possible that the excessive amount of SAg in optimal 
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stimulation conditions may directly interact with CD28 and induce strong co-stimulatory 
signals that differentially activates TNF receptor superfamily signaling pathways leading 
to CD8+CD25+FOXP3+ T cells without a suppressive activity. Further study is 
necessary to determine the role of SAg interaction with CD28 in the functional 
maturation of CD8+ Tregs. 
A number of studies have reported diverse mechanisms of immunosuppression by 
CD8+ Treg. The CD8+ Tregs originally reported in the murine model interacted with 
activated CD4+ T cells expressing the MHC class 1b molecule, Qa-1, via TCR and 
suppressed self-reactive autologous CD4+ T cells [193]. Clinical studies in humans 
revealed that human CD8+ Tregs interacted with the HLA-E, equivalent to murine Qa-1, 
expressed on self-reactive CD4+ T cells and suppressed self-reactive CD4+ T cells by 
killing antigen-activated autologous CD4+ T cells in autoimmune type 1 diabetes and 
multiple sclerosis [194]. Other types of CD8+ Tregs suppressed immune responses by 
mediating negative signals to APC via cell-to-cell interaction such as CTLA-4 and 
CD80/86 and immunoglobulin-like transcript (ILT) 3 and ILT4 on APC [117], inducing 
immunomodulatory cytokines such as TGF- and/or IL-10, and altering metabolic 
activities such as inducing cytotoxic tryptophan catabolism through induction of 
indoleamine 2,3-dioxygenase (IDO) [114]. We determined the role of CTLA-4, IFN-, 
IL-10, TGF-, cAMP, and COX previously described to mediate immunosuppression by 
Tregs. However, none of these molecules were responsible for immunosuppression by 
CD8+CD25+ T cells induced by suboptimal stimulation with SEC1.  
In a search for unique phenotypic and functional markers of CD8+ Treg, we 
found that galenctin-1 and granzyme A and B were consistently upregulated in 
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CD8+CD25+ T cells from our RNA-seq and proteomics analyses. Galectin-1, a member 
of -galactoside-binding proteins, is expressed by thymic epithelial cells, activated CD8+ 
T cells, and macrophages and is secreted by a non-canonical mechanism that bypasses the 
endoplasmic reticulum and the Golgi apparatus [195]. Galectin-1 interacts with CD4, 
CD7, CD43, CD45, and CD69 and extracellular matrix glycoproteins such as laminin, 
fibronectin, and vitronectin and regulates cell homeostasis and inflammation [196]. 
Previous studies demonstrated that addition of galectin-1 to activated human T cells and 
leukemic cell lines triggers the clustering and polarization of CD7, CD43, and CD45, 
followed by signaling events leading to apoptosis [195]. A recent study demonstrated that 
galectin-1 is highly expressed and secreted in activated CD4+CD25+ Treg and the 
blockade of galectin-1 by anti-Gal-1 mAb significantly reduced the suppressive activity 
of CD4+CD25+ Treg, suggesting that galectin-1 is a key effector molecule for immune 
regulation [72]. Granzymes are serine proteases that induce apoptosis of target cells by 
activating a caspase cascade. Several studies have demonstrated that CD4+CD25+ Treg 
also express granzyme A and/or B and induce apoptosis in various autologous immune 
cells in a perforin-dependent but FasL independent manner [197]. In our study, the 
blockade of galectin-1 and granzymes using an anti-Gal-1 mAb and DCI significantly, 
but not completely, inhibited the suppressive activity of CD8+CD25+ T cells induced 
from suboptimal stimulation with SEC1. These results indicate that while galectin-1 and 
granzymes are mainly responsible for the suppression, there are additional mechanism of 
suppression. Combined results from autologous MLR using mitomycin C-treated 
CD8+CD25+ T cells and transwells with anti-Gal-1 mAb strongly suggest that contact 
dependent suppression is mediated by galectin-1. However, it is noteworthy that 
 
49 
expression of galectin-1 was only detected intracellularly and that galectin-1 was also 
highly expressed in CD8+CD25+ T cells induced by optimal stimulation with SEC1. 
These results raise questions regarding the role of galectin-1 in immune suppression by 
CD8+CD25+ T cells induced by optimal stimulation with SEC1. It is possible that the 
anti-Gal-1 mAb recognizes an epitope involved in binding to its receptor so that anti-Gal-
1 mAb is able to neutralize the binding of galectin-1 to receptors, but unable to detect 
galectin-1 bound to the receptors on the surface of CD8+CD25+ T cells induced by 
suboptimal and optimal stimulation with SEC1 since the epitope for anti-Gal-1 mAb is 
occupied with its receptors. It is also possible that CD8+CD25+ T cells induced by 
suboptimal stimulation with SEC1 express a unique surface protein that interacts, either 
directly or indirectly, with galectin-1 to mediate the contact-dependent suppression. 
These possibilities are currently under investigation. Elucidating the galectin-1 receptor 
and its ligand on the target cells would be critical to identify specific surface markers of 
Tregs and understand their suppression mechanism.  
In conclusion, our results clearly demonstrate the contribution of SAgs expressed 
at low concentrations in the pathogenesis of S. aureus by inducing immunosuppressive 
CD8+ Tregs that can deteriorate host cellular immunity leading to bacterial colonization, 
spreading, and eventually to highly lethal invasive infections. Several population 
genomics studies revealed that both commensal and clinical S. aureus strains more 
frequently harbor 5-6 SAgs genes (seg, sei, sem, sen, seo, and/or seu) clustered in the 
enterotoxin gene cluster (egc) [168, 198-201]. These SAgs are intrinsically regulated to 
be expressed at low concentrations which have a potential to induce Tregs. These results 
further support the biological fitness of S. aureus strains expressing SAgs at low 
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concentrations in the pathogenic evolution of S. aureus. Further study investigating 
alteration of cellular signaling pathways in a SAg concentration dependent manner and 
molecular mechanisms of immunosuppression by CD8+ Tregs will warrant to design 





INDUCTION OF IMMUNOSUPPRESSIVE CD4+CD25+FOXP3+ REGULATORY 
T CELLS BY SUBOPTIMAL STIMULATION WITH 
STAPHYLOCOCCAL ENTEROTOXIN C1 
3.1 Abstract 
Staphylococcal enterotoxins (SEs) and toxic shock syndrome toxin-1 (TSST-1) 
produced by Staphylococcus aureus are superantigens with a prominent characteristic of 
inducing massive activation of T cells and proinflammation, leading to toxic shock 
syndrome. Paradoxically, increasing evidence indicates that superantigens also induce 
strong immunosuppression by inducing development of regulatory T cells. Here, we 
demonstrated that suboptimal stimulation of human peripheral blood mononuclear cells 
(PBMCs) with a low concentration (1 ng/ml) of staphylococcal enterotoxin C1 (SEC1) 
induced immunosuppressive CD4+CD25+FOXP3+ T cells whereas optimal stimulation 
with a high concentration (1 µg/ml) of SEC1 induced non-immunosuppressive 
CD4+CD25+FOXP3+ T cells. The suppression was mainly mediated in a contact-
dependent manner via galectin-1. Both optimal and suboptimal stimulations induced 
activation of Akt and mammalian target of rapamycin (mTOR) pathway, leading to 
expression of FOXP3. However, expression of the lipid phosphatase and tensin homolog 
(PTEN) was only highly induced by suboptimal stimulation. These results suggest an 
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important role of PTEN in functional divergence in CD4+CD25+ T cells in optimal and 
suboptimal stimulation with superantigen. 
3.2 Introduction 
Staphylococcus aureus is a Gram-positive bacterium that resides in skins, nasal 
mucosa, and respiratory tract of 30 to 40 % of healthy adults at any given time and 70 % 
of people experience S. aureus colonization without any symptom in their lifetime [202]. 
S. aureus also opportunistically causes a multitude of diseases from mild soft tissue 
infections to life threating diseases such as infective endocarditis, sepsis, necrotizing 
pneumonia, abscess, and toxic shock syndrome (TSS) [1].  
Staphylococcal enterotoxins (SEs) and toxic shock syndrome toxin-1 (TSST-1) 
are superantigens (SAgs) that bind directly to the variable region of a subset of -chains 
of the TCR and to MHC II. These interactions allow a single SAg to activate up to 25 % 
of T cells in the periphery and to elicits extensive proinflammatory immune responses 
causing TSS [146, 147]. However, S. aureus more frequently colonize skins and mucosa 
where low amounts of SAg are produced at insufficient to cause TSS [2-4]. The role of 
such low amounts of SAgs in S. aureus pathogenesis has not been fully appreciated.  
Regulatory T cells (Tregs) play an important role in maintaining immune 
homeostasis, preventing autoimmune diseases, and balancing immune responses during 
infections to prevent excessive tissue damage [7-10]. However, pathogens also develop a 
strategy to exploit Tregs to establish successful infections by suppressing host immune 
response. We have recently reported that stimulation of human PBMCs with SEC1 
induced CD8+CD25+FOXP3+ T cells with a striking functional difference depending on 
the strength of stimulation modulated by the concentration of SEC1. 
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CD8+CD25+FOXP3+ T cells induced by stimulation with 1 ng/ml of SEC1 showed 
strong contact-dependent suppressive activity which was largely mediated by galectin-1. 
By contrast, CD8+CD25+FOXP3+ T cells induced by stimulation with 1 µg/ml of SEC1 
were not immunosuppressive. Similar to these findings, other studies also demonstrated 
the induction of immunosuppressive Treg by suboptimal stimulation with low dose 
antigens [47, 50]. However, the molecular mechanism by which suboptimal stimulation 
of T cell induce development of Treg has not been fully understood. 
In this study, we stimulated human PBMCs with SEC1 at the dose inducing 
maximal and a half maximal T cell proliferation as optimal and suboptimal stimulation 
conditions, respectively. We determined the phenotypic and functional characteristics of 
CD4+CD25+ T cells induced by stimulation with SEC1. We further compared 
differential induction of cellular signaling pathways involved in T cell activation, 
differentiation, and maturation to understand the mechanism of functional divergence 
depending on the strength of T cell activation modulated by the concentration of 
superantigen.  
3.3 Materials and methods 
3.3.1 PBMC isolation  
Blood samples were collected from healthy donors after informed consent had 
been obtained, in accordance with the protocol (13-191) reviewed and approved by the 
Institutional Review Board at Mississippi State University. Blood was obtained by 
venipuncture, and peripheral blood mononuclear cells (PBMCs) were prepared from 
EDTA-treated whole blood by gradient centrifugation using Histopaque 1.077 (Sigma-
Aldrich, St. Louis, MO). The isolated PBMCs were resuspended in RPMI 1640 medium 
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containing 10% heat-inactivated FBS and 1% penicillin-streptomycin (Invitrogen, 
Carlsbad, CA).  
3.3.2 Purification of SEC1 
Dr. Scott Minnich (University of Idaho) kindly provided staphylococcal 
enterotoxin C1 (SEC1) which was purified from S. aureus RN4220 (pMIN121) using 
preparative isoelectric focusing with a broad isoelectric point (3 to 10) and a narrow 
isoelectric point (6 to 8) range of ampholytes in succession [159]. 
3.3.3 Cell stimulation  
To determine the concentration of SEC1 inducing maximal and a half maximal T 
cell proliferation to set optimal and suboptimal stimulation condition, respectively, 
PBMCs were stimulated with various concentrations of SEC1 (0.001-10,000 ng/ml) in 
96-well plate at 5 × 10
5
 cells per well and incubated at 37 ℃ in 5% CO2 for 3 days. Cells 
were pulsed with 1 μCi of [
3
H]-thymidine and cultured for additional 18 hours. Cellular 
DNA was harvested on glass fiber filters, followed by quantification of [
3
H]-thymidine 
incorporation measured by liquid scintillation counting. 
To prevent potential expansion of preexisting regulatory T cells, CD25+ cells 
were depleted from PBMCs using CD25 microbead (Miltenyi Biotec, San Diego, CA). 
The PBMCs depleted of CD25+ cells (PBMC/CD25-) were adjusted to 1.5 × 10
6
 cells per 
well in 6-well plate. For optimal and suboptimal stimulation, PBMC/CD25- was 
stimulated with SEC1 at the 1 μg/ml and 1 ng/ml, respectively, for the indicated times.  
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3.3.4 Immunophenotyping and flow cytometry  
For phenotypic analysis of CD4+CD25+ T cells induced from SEC1 stimulation, 
mAbs specific to human CD4-FITC, CD25-PE/Cy7, IL-2-PE, IL-10-PE and CD45RO-PE 
were purchased from BD Biosciences (San Jose, CA). The mAbs specific to human 
FOXP3-allophycocyanin, CD28-PE, CD127-PE, HLA-DR-PE, OX40-PE, GITR-PE, and 
CTLA-4-PE were purchased from eBioscience (San Diego, CA). anti-TGF-β-PE was 
purchased from R&D systems (Minneapolis, MN). Anti-human CD120b-PE (TNFR2) 
was purchased from BioLegend (San Diego, CA). Anti-human galectin-1-AlexaFluor647 
was purchased from Santa Cruz Biotechnology (Dallas, TX).  
For surface staining, cells were harvested, washed with FACS buffer 
(eBioscience) and stained for 30 min at 4℃ with CD4-FITC, CD25-PE/Cy7, CD28-PE, 
CD45RO-PE, CD127-PE, HLA-DR-PE, OX40-PE, GITR-PE, TNFR2, TCR Vβ2-PE, or 
TCR Vβ14-PE. For enhanced detection of intracellular cytokines, brefeldin A 
(eBioscience) was added to stimulated PBMC culture 2 h before harvesting. Following 
surface staining, cells were fixed and permeabilized with the FOXP3/transcription factor 
staining buffer set (eBioscience). Fixed/permeabilized cells were stained with FOXP3- 
allophycocyanin, IL-2-PE, IL-10-PE, TGF-β1-PE, galectin-1-AlexaFluor647 or CTLA-4-
PE for 30 min at room temperature.  
After further washing, stained cells were acquired using a FACSAria III or a 
FACSCalibur flow cytometers equipped with FACSdiva or CellQuest software, 
respectively (Becton Dickinson Immunocytometry Systems, San Jose, CA). Data was 
analyzed using FlowJo software (Tree Star, Ashland, OR). Fluorescence minus one 
(FMO) controls or isotype controls were used. 
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3.3.5 Suppression assays 
For suppression assays, CD4+CD25+ T cells and CD4+CD25- T cells were 
purified from optimal and suboptimal stimulation of PBMC/CD25- cells with SEC1 by 
negative selection using a human CD4+ Isolation kit (Miltenyi Biotec, Auburn, CA), 
followed by human CD25 microbeads II kit (Miltenyi Biotec) according to the 
manufacturer’s instruction. These cells were further labeled using a CellTrace FarRed kit 
(Invitrogen) to separate Treg from responder cells in the autologous mixed leukocyte 
reaction (MLR).  
Autologous naïve CD4+CD25- T cells were purified from naive PBMC/CD25- 
using a human CD4+ isolation kit (Miltenyi Biotec). These cells were labeled with 5,6-
carboxyfluorescein diacetate succinimidyl ester (CFSE, eBioscience) to track the 
proliferation response to anti-CD3/CD28 Dynabeads (Life technologies, Carlsbad, CA). 
The purity of isolated cells was consistently 95-99 % as determined by flow cytometry 
analysis (data not shown). 
For the suppression assay, FarRed-labeled SEC1-stimulated CD4+CD25+ T cells 
(1 × 10
5
, 5 × 10
4
) were mixed with CFSE-labeled naïve CD4+CD25- T cells (1 × 10
5 
cells per well, responder cells) in round-bottom 96-well plate. Cells were stimulated with 
anti-CD3/CD28 Dynabeads at a 1:1 bead to naïve T cell ratio. After 4 days, proliferation 
of CFSE-labeled CD4+ T cells was determined as the dilution of CFSE signal using a 
Novocyte flow cytometer (Acea Biosciences). For the contact-dependent suppression 
assay, SEC1-stimulated CD4+CD25+ T cells were treated with 10 µM of mitomycin C 
(Sigma-Aldrich) for 2 hours at 37℃ to prevent them from proliferating. After thorough 
washing with PBS, cells were co-cultured with naïve CD4+ T cells in the presence of 
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anti-CD3/CD28 beads. For soluble factor-dependent suppression assay, SEC1-stimulated 
CD4+CD25+ T cells (1 × 10
5
) were placed in the upper chamber of transwell (0.45 μm 
pore size, Corning Life Sciences, Tewksbury, MA) and autologous CFSE-labeled naïve 
CD4+CD25- T cells (1 × 10
5
) were added to the bottom chamber and stimulated with 
anti-CD3/CD28 Dynabeads for 4 days. 
In some experiments, mAbs against IL-10 (R&D systems), TGF-β1 (R&D 
systems), CTLA-4 (eBioscience), and isotype controls (eBioscience) were added at a 
final concentration of 10 μg/ml in the culture. Antibody to galectin-1 was added at 0.1 
μg/ml in the culture (Santa cruz biotechnology) to the CD4+CD25+ T cell culture and 
incubated for one hour prior to co-culture with responder cells. Additionally, 25 µM of 
Indomethacin (COX-inhibitor, Sigma-Aldrich), 10 µM of ZM 241385 (Adenosine 2A 
antagonist, Tocris, Minneapolis, MN), or 50 µM of 3,4-dichloroisocumarin (serine 
protease inhibitor, EMD Millipore, Billerica, MA) were added to determine mechanisms 
of suppression. 
3.3.6 Protein extraction and immunoblot analysis 
Total protein was extracted by lysing stimulated PBMCs with RIPA buffer 
(Fisher), plus protease inhibitor (GE sciences) and phosphatase inhibitor (ThermoFisher). 
Protein concentration was determined and equal amounts of protein were loaded onto an 
8 % or 12.5 % denaturing acrylamide gel. Separated proteins were transferred to PDVF 
membrane. Immunoblotting was performed using the following mAbs from Cell 
Signaling Technology: phospho-mTOR (Ser2448), Akt, S6, phospho-S6 (Ser240/244), 
and PTEN. mAb against phospho-Akt (11E6, Ser473) was purchased from Santa cruz 
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biotechnology. The loading control was assessed by immunoblot using anti-β-actin Ab 
(Sigma-Aldrich). 
3.3.7 Statistical analysis 
Statistical significance among different treatment groups was analyzed with the 
student t test or the one-way analysis of variance (ANOVA), followed by Tukey’s HSD 
for post hoc test using GraphPad Prism software (Version 7.0.3. La Jolla, CA). 
Differences with p value < 0.01 or 0.001 were considered statistically significant as 
indicated in each experiment. 
3.4 Results 
3.4.1 Stimulation of human PBMCs with SEC1 induced FOXP3 expression in 
CD4+ T cells  
To determine SEC1 concentrations that induce maximal and half maximal 
proliferation of T cells, we measured human T cell proliferation in response to 
stimulation with a various concentration of SEC1 (0.01 to 10,000 ng/ml). The T cell 
proliferation was positively related to the concentration of SEC1 and the maximal T cell 
proliferation was observed at 1 μg/ml whereas half maximal T cell proliferation was 
observed at 1 ng/ml (Fig. 3.1A). Therefore, we defined the optimal strength stimulation 
condition as 1 μg/ml, which induces maximal proliferation and the suboptimal strength 
stimulation condition as 1 ng/ml, which induces half-maximal proliferation, respectively. 
To examine the strength of T cell stimulation on expression of FOXP3 in 
CD4+CD25+ T cells, CD25-depleted human PBMCs were stimulated with optimal (1 
μg/ml) and suboptimal (1 ng/ml) concentration of SEC1 for up to 8 days. In optimal 
stimulation, expression of FOXP3 gradually increased and peaked at day 4, then 
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decreased thereafter. In suboptimal stimulation, expression of FOXP3 was delayed until 
day 4, peaked at day 6 and sustained until day 8 (Fig. 3.1B & C). 
We confirmed that the expansion of FOXP3-positive T cells from suboptimal 
stimulation was due to SEC1 by measuring SEC1-specific Vβ sequences of FOXP3+ T 
cells (Appendix fig. 4). 
 
Figure 3.1 FOXP3 expression in CD4+CD25+ T cells stimulated under optimal and 
suboptimal condition. 
(A) Proliferation of human T cells after stimulation with various concentration of SEC1 was measured by 
the incorporation of 
3
[H]-thymidine. The data shown are the mean ± SEM of nine independent experiments. 
(B) Human PBMCs were incubated with optimal and suboptimal condition with SEC1. FOXP3 expression 
before and after stimulation was measured. Percentage (mean ± SEM) of CD4+CD25+FOXP3+ T cells 
were obtained with data combined from nine independent experiments. (C) Data shown is a representative 
of nine independent experiments and gated on CD4+ T cells. 
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3.4.2 Suboptimal stimulation induces functionally immunosuppressive 
CD4+CD25+ T cells 
As FOXP3 could be transiently expressed in effector CD4+CD25+ T cells, we 
determine the functionality of CD4+CD25+ T cells induced from optimal and suboptimal 
stimulation with SEC1 using an autologous MLR assay. As expected, CFSE-labeled 
naïve CD4+CD25- T cells proliferated well in response to anti-CD3/CD28 beads which 
was indicated as a gradual dilution of CFSE signal (Fig. 3.2B). CD4+CD25+ T cells 
induced from suboptimal stimulation with SEC1 completely inhibited proliferation of 
naïve CD4+CD25- T cells (Fig. 3.2C), whereas CD4+CD25+ T cells induced from 
optimal stimulation with SEC1 failed to inhibit proliferation (Fig. 3.2D). It is noteworthy 
that CD4+CD25+ T cells induced from optimal and suboptimal stimulation with SEC1 
were labeled with CellTrace FarRed dye and these cells continuously proliferated during 
the autologous MLR in the presence or absence of naïve CD4+CD25- T cells. Taken 
together, these results indicated that CD4+CD25+ T cells induced from suboptimal 
stimulation with SEC1 were functionally immunosuppressive, but cells given optimal 
stimulation were not functionally immunosuppressive. Suppression was specific to naïve 





Figure 3.2 CD4+CD25+ T cells induced from suboptimal stimulation are 
immunosuppressive. 
(A) Percentage (mean ± SEM) of non-proliferating responder cells from nine independent experiments. (B) 
Naïve CD4+CD25- T cells were isolated and stained with CFSE. Proliferation of CD4+ T cells was 
measured before and after stimulation with anti-CD3/CD28 beads. (C) CD4+CD25+ T cells induced from 
suboptimal (C) or optimal (D) stimulation with SEC1 were stained with CellTrace Far Red and co-cultured 
with CFSE-labeled CD4+ T cells at 1:1 ratio in the presence of anti-CD3/CD28 beads. Gating on each cell 
population is shown in the center dot plot in 3.2C and 3.2D. 
Next, we questioned whether the suppression by CD4+CD25+ T cells induced by 
suboptimal stimulation with SEC1 is mediated by cell-to-cell contact or soluble factors. 
To examine contact-dependent suppression, CD4+CD25+ T cells induced after 
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suboptimal stimulation with SEC1 were treated with mitomycin C to prevent de novo T 
cell activation. The mitomycin C-treated CD4+CD25+ T cells completely inhibited 
proliferation of naïve CD4+CD25- T cells (Fig. 3.3). However, the suppression by 
CD4+CD25+ T cells induced by suboptimal stimulation with SEC1 placed in a transwell 
decreased proliferation of naïve T cells by approximately 40% compared to the contact 
dependent manner. These results suggest that the suppression by CD4+CD25+ T cells 
induced from suboptimal stimulation with SEC1 is mainly mediated by cell-to-cell 
contact, but soluble factors are also involved. 
 
Figure 3.3 Predominant cell-to-cell contact-dependent suppression by CD4+CD25+ T 
cells induced by suboptimal stimulation. 
CD4+CD25+ T cells were isolated from PBMCs after stimulation with a suboptimal concentration of SEC1 
and stained with CellTrace Far Red. CD4+CD25+ T cells were treated with mitomycin C for the contact-
dependent suppression assay or placed in the top chamber of a transwell for the soluble factor-mediated 
suppression assay. CFSE-labeled naïve CD4+CD25- T cells were co-cultured as responder cells and 
stimulated with anti-CD3/CD28 beads. (A) A single representative result is shown. (B) Percentage (mean ± 




3.4.3 Expressions of Treg-related surface markers and cytokines in 
CD4+CD25+FOXP3+ T cells from suboptimal stimulation 
 
Figure 3.4 CD4+CD25+ T cells induced by suboptimal stimulation express surface 
markers and cytokines related to Tregs. 
Human PBMCs were stimulated with a suboptimal concentration of SEC1 for up to 6 days and expression 
of cytokines and surface markers related to Treg were analyzed using flow cytometry. Data shown are 
combined results from nine independent experiments. Cells were treated with brefeldin A for 2 hrs prior to 
staining and cytokines were measured by intracellular staining. Percentage (mean ± SEM) of CD4+CD25+ 
T cells expressing cytokines (A) and surface markers related to Tregs (B). 
Next, we characterized phenotypes of CD4+CD25+FOXP3+ T cells induced by 
the suboptimal stimulation with SEC1 using flow cytometry. Upon suboptimal 
stimulation with SEC1, CD4+CD25+ T cells barely expressed IL-2, IL-10, and TGF-β 
until day 2. Expression of IL-2 rapidly increased at day 4 then decreased at day 6 (Fig. 
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3.4A). Expression IL-10 and TGF-β gradually increased throughout the stimulation 
period. CD4+CD25+FOXP3+ T cells induced by suboptimal stimulation highly 
expressed CD45RO, CTLA-4, HLA-DR, and TNFR2 and moderately expressed CD127, 
GITR, and OX40 (Fig. 3.4B). It is noteworthy that expression of CTLA-4 was barely 
detected on the cell surface but was highly expressed intracellularly. These results are in 
line with previously described phenotypes of Tregs by us [159] and others [10, 58]. 
3.4.4 Galectin-1 mediates the contact-dependent suppression by 
CD4+CD25+FOXP3+ T cells induced by suboptimal stimulation with 
SEC1  
Next, we investigated the mechanisms of suppression by CD4+CD25+FOXP3+ T 
cells induced by the suboptimal stimulation with SEC1. As CTLA-4, IL-10, and TGF-β 
are involved in contact-dependent or in soluble factor dependent suppression by Tregs in 
other models [61, 62, 66, 203], we tested neutralizing Ab against CTLA-4, IL-10, and 
TGF-β, but failed to restore proliferation of naïve CD4+CD25- T cells (Fig. 3.5A, top 
panel). 
As increased intracellular cAMP caused by activation of adenosine receptor 2A 
and COX-2 in Tregs suppressed IL-2 production and T cell proliferation [83], we used an 
adenosine receptor 2A inhibitor (ZM241685) and a COX-2 inhibitor (indomethacin) in 
autologous MLR. Neither treatment abrogated suppression by CD4+CD25+ T cells 
induced by suboptimal stimulation with SEC1 (Fig. 3.5A, lower panel). 
Since we recently demonstrated the suppression by CD8+CD25+FOXP3+ T cells 
induced by suboptimal stimulation with SEC1 was mediated by galectin-1 [159], we 
measured expressions of galectin-1 on CD4+CD25+ T cells induced by suboptimal 
stimulation with SEC1. Galectin-1 was mainly detected by intracellular labeling and, to a 
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significantly lesser extent, by surface labeling (Fig. 3.5B). The addition of anti-Gal-1 
mAb in the autologous MLR assay partially restored proliferation of naïve CD4+CD25- 
T cells to approximately 60-65 %, as compared to cells without anti-Gal-1 mAb (Fig. 
3.5C & D). The addition of anti-Gal-1 mAb to mitomycin C-treated CD4+CD25+ T cells 
fully restored proliferation of naïve CD4+CD25- T cells (Fig. 3.5C & D). Taken together, 
these results strongly suggest that galectin-1 is responsible for contact-dependent 




Figure 3.5 Galectin-1 mediates contact-dependent suppression by CD4+CD25+ T 
cells induced from suboptimal stimulation with SEC1. 
(A) CD4+CD25+ T cells from suboptimal stimulation were isolated and co-cultured with CFSE-labeled 
naïve CD4+CD25- T cells at 1:1 ratio in the presence of anti-CD3/CD28 beads for 4 days. Neutralizing 
mAb (10 µg/ml) for CTLA-4, IL-10, and TGF-β, indomethacin (25 µM, COX inhibitor), or ZM241385 (10 
µM, adenosine 2A antagonist) was added as indicated. (B) Galectin-1 expression in CD4+CD25+FOXP3+ 
T cells induced by suboptimal stimulation. (C) anti-galectin-1 mAb was added in an MLR reaction with or 
without mitomycin C treatment of CD4+CD25+ T cells or in transwell. Percentage (mean ± SEM) of non-
proliferating CD4+ T cells were obtained from combined results from nine independent experiments. (D) 
Data shown are a representative dot plots from nine independent experiments. 
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3.4.5 Differential activation of PI3K-Akt-mTOR pathways depending on the 
strength of superantigen stimulation 
 
Figure 3.6 Differential activation of PI3K-Akt-mTOR pathway in optimal and 
suboptimal stimulation with SEC1. 
PBMCs were stimulated with optimal or suboptimal concentration of SEC1 for up to 6 days and total 
protein was extracted at indicated time. Immunoblot analysis of total and/or phosphorylated S6, Akt, 
mTOR, PTEN, and β-actin. Results shown are a single representative immunoblot data (left). The band 
intensity was measured using ImageJ software. Relative band intensity was calculated by normalizing the 
band intensity to its total protein (for S6 and Akt) or β-actin (for mTOR and PTEN). Results combined 
from three independent experiments were shown (Right). Statistical significance between optimal and 
suboptimal stimulation was determined by student t test (*p<0.01, ** p <0.001, *** p <0.0001).  
As the downstream of TCR signaling via PI3K, p110α, p110δ, Akt, and mTOR 
play an important role in expression of FOXP3 [51, 204], we investigated differential 
activation of these signaling pathways in CD4+CD25+ T cells induced by optimal and 
suboptimal stimulation with SEC1 (Fig. 3.6). Expression of PTEN (phosphatase and 
tensin homolog), which negatively regulates the PI3K activity [205], was slightly 
increased until day 1 and then gradually decreased thereafter in optimal stimulation. By 
contrast, expression of PTEN was gradually increased and peaked at day 4, and then 
decreased thereafter. Phosphorylation of Akt at serine 473 was comparable in both 
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stimulation conditions and remained constant throughout the stimulation periods. In 
optimal stimulation, the phosphorylation of mTOR was gradually increased, peaked at 
day 4 and rapidly decreased thereafter. In suboptimal stimulation, phosphorylation of 
mTOR spiked at day 4. Upon optimal stimulation, phosphorylation of S6 protein was 
increased and sustained until day 4. By contrast, the phosphorylation of S6 protein was 
delayed until day 4 and increased at day 6 in suboptimal stimulation 
3.5 Discussion 
In this study, we demonstrated that the strength of T cell stimulation modulated 
by the concentration of superantigen remarkably influences the functional characteristics 
of CD4+CD25+ T cells. We showed that expression of FOXP3 in CD4+CD25+ T cells 
was induced by both optimal and suboptimal stimulation of PBMC with SEC1. However, 
only the CD4+CD25+ T cells induced by suboptimal stimulation are immunosuppressive 
Tregs. These results suggest that expression of FOXP3 is necessary but not sufficient to 
the functional maturation of immunosuppressive Treg. The FOXP3 is a transcriptional 
factor which is essential for induction and maturation of Tregs. However, FOXP3 biology 
in humans is quite complicated. Although murine FOXP3 is exclusively expressed in 
CD4+CD25+ Tregs, human FOXP3 can be transiently expressed in effector CD4+ T cells 
following TCR activation. Only one form of FOXP3 is observed in mice, but at least 4 
different alternatively spliced FOXP3 transcripts have been identified in humans (3, 24-
26). The human FOXP3 gene is located on the X chromosome and contains 11 coding 
exons (exons 1-11) (27). Each exon encodes distinct functional domains comprised of an 
N-terminal proline-rich domain (a.a. 1-193) responsible for transcriptional repression, a 
zinc finger (a.a. 200-223), a leucine-zipper-like motif (a.a. 240-261) responsible for 
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homo-dimer or tetramer formation, and a C-terminal FKH domain (a.a. 388-421) 
responsible for DNA binding [36]. Since alternative splicing is a highly regulated 
biological process that generates multiple functional proteins from a single gene, 
alternatively spliced isoforms of human FOXP3 may have different functions, depending 
on what functional domains are present. It is of interest to investigate the FOXP3 
isoforms present in optimal and suboptimal stimulation which would reveal the specific 
FOXP3 isoforms leading to functional maturation of suppressive Tregs. 
We identified galectin-1 as the effector molecule exerting cell-to-cell contact 
mediated suppression in Tregs induced by suboptimal stimulation with SEC1. It is 
noteworthy that SEC1-induced Tregs could suppress responder T cells in the absence of 
accessory cells such as APCs, indicating direct contacts between CD4+CD25+ T cells 
and responder T cells for suppressive activity. Galectin-1 is a member of carbohydrate-
binding protein family which has emerged as a novel regulator of immune response. The 
immunoregulation by galectin-1 is conferred via inducing apoptosis of activated T cells 
[206]. In line with our finding, suppression by galectin-1 was demonstrated in human 
tTregs by Garin et al. [72]. Although galectins are considered soluble proteins, the 
presence of surface-bound galectin-1 has been described [72, 207, 208], which supports 
the potent contact dependent suppression in our study. In SEC1-induced Tregs the 
majority of galectin-1 resided in the cell while a relatively small portion of galectin-1 was 
located on the cell surface (Fig.3.5B). It is undetermined how galectin-1 selectively 
induces apoptosis of activated responder T cells without harming SEC1-induced Tregs. 
Despite the sharp difference in suppressive function, CD4+CD25+ T cells from optimal 
and suboptimal stimulation express similar levels of galectin-1 intracellularly and on the 
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cell surface (Fig. 5B, Appendix fig.5). This indicates the possibility of additional 
mechanisms which enable galectin-1 to act functionally in Tregs induced by suboptimal 
stimulation. Galectin-1 is secreted in an ER/Golgi-independent way and is thought to be 
packaged into intracellular vesicles (exosomes) prior to export . However, it remains 
elusive how galectin-1 accumulates at the plasma membrane and what triggers vesicle 
formation. Therefore, TCR signal strength may regulate accumulation of galectin-1 
and/or vesicle formation for secretion of galectin-1. It is also possible that galectin-1 
binds to specific receptors exclusively expressed on Tregs induced from suboptimal 
stimulation, which allows galectin-1 to confer suppressive activity by cell-to-cell contact. 
A recent murine study identified that galectin-9 binds to the extracellular domain of 
Death Receptor 3 (TNFRSF25) in Tregs, thereby playing a role in expansion and function 
of Tregs [209]. We are currently investigating binding partners of galectin-1 specifically 
expressed on cell membrane of Tregs induced from suboptimal stimulation with SEC1. 
TCR signal strength, determined by antigen dose, drives T cell fate [47]. Among 
TCR downstream signaling pathways, the PI3K-Akt-mTOR pathway is specifically 
considered a gate controller that dictates T cell differentiation into effector T cells or 
Tregs [51]. Thymus-derived Tregs exhibit diminished Akt phosphorylation compared 
with effector T cells [204] and abrogation of activation signals in the PI3K-Akt-mTOR 
pathway is necessary for Treg differentiation [210, 211]. Mammalian/mechanistic target 
of rapamycin (mTOR) is important for the regulation of T cell activation, differentiation, 
and function. In general, mTOR in T cells is activated by TCR engagement in the 
presence of costimulation as well as cytokines. Upon T cell activation via TCR 
engagement, the PI3K-Akt signaling pathway is induced which activates two distinct 
 
71 
mTOR complexes; mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The 
mTOR1 activity is typically assessed by the phosphorylation of S6 kinases, while the 
mTORC2 activity is assessed by the phosphorylation of Akt at serine 473 [212]. The 
activation of mTORC1 typically enhances protein synthesis and alters metabolism that 
promotes cell growth, proliferation, and survival. The activation of mTORC2 also 
enhances cell survival, metabolism, and cytoskeletal rearrangement [212]. It has been 
proposed that the induction of mTORC1 activity in FOXP3+ Treg via TCR-PI3K-Akt 
signaling activates metabolism of lipid biosynthesis and cholesterol that triggers 
proliferation of Treg, and induces expression of CTLA-4 and ICOS to mediate 
suppression by Treg [213]. In contrast, the induction of mTOR1 activity in naïve CD4+ T 
cells via TCR-PI3K-Akt signaling inhibits expression of FOXP3 and favors the 
generation of Th1, Th2, and Th17 T cells [210]. In this study, we removed CD25+ T cells 
from PBMCs to prevent expansion of preexisting tTreg in PBMCs. Thus, our cellular 
signaling analysis was from naïve CD4+CD25- T cells responding to the superantigen. 
Interestingly, in both stimulation conditions, the phosphorylation of mTOR and S6 was 
coincident with or preceding the expression of FOXP3. The phosphorylation of Akt at 
serine 473 was sustained in both stimulation conditions. These results indicated that 
expression of FOXP3 was induced while both mTORC1 and mTORC2 activity were 
induced. These results were also somewhat contradictory to previously proposed roles of 
mTORC1 in naïve CD4+ T cells described above. As the proposed role of mTOCR1 in 
tTreg and naïve CD4+ T cells was largely based on murine models, it still remains 
elusive whether the role of mTORC1 activity in inducing FOXP3 expression is different 
in humans or unique to superantigens. 
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In the current study, CD4+CD25+FOXP3+ T cells induced by suboptimal 
stimulation matured under high expression of PTEN whereas CD4+CD25+FOXP3+ T 
cells induced from optimal stimulation matured under minimal expression of PTEN. The 
lipid phosphatase PTEN antagonizes the catalytic action of PI3K. Thus, expression of 
PTEN inhibits induction of PI3K-Akt-mTOR signaling, thereby promoting development 
of Treg. Recent studies demonstrated that antigen dose controls PTEN expression and 
function which leads to Treg differentiation [214] and targeted deletion of PTEN causes 
instability of Treg, leading to the conversion of Treg into proinflammatory effector cells, 
so-called ex-Treg [52]. These results suggest that PTEN signaling might be a critical 
driver of functional divergence in CD4+CD25+FOXP3+ T cells induced by optimal and 
suboptimal stimulation with superantigen. 
Staphylococcal superantigens have been well characterized for their ability to 
provoke extensive T cell activation and hyperinflammation, leading to fatal TSS which 
occurs when hosts are exposed to microgram quantities of superantigens [215]. However, 
our data demonstrated that immunosuppressive Tregs were induced from suboptimal 
stimulation of T cells with superantigens which more frequently occurs during 
asymptomatic colonization of S. aureus in hosts. The established in vitro model will be 
useful to understand the mechanisms of TSS and immunosuppression, two paradoxical 





DIFFERNTIAL EXPRESSION OF FOXP3 ISOFORMS IN HUMAN REGULATORY 
T CELLS INDUCED BY SUBOPTIMAL STIMULATION WITH 
STAPHYLOCOCCAL ENTEROTOXIN C1 
4.1 Abstract 
Forkhead box P3 (FOXP3) is a central transcription factor for development and function 
of regulatory T cells. However, the role of FOXP3 expressed in human conventional T 
cells upon activation is not fully understood. Here, we investigated profiles of FOXP3 
isoforms in CD4+ and CD8+ T cells stimulated with staphylococcal enterotoxin C1 
(SEC1) at the concentrations inducing the suboptimal and the optimal stimulation, 
resulting in generation of immunosuppressive FOXP3+ T cells and non-suppressive 
FOXP3+ T cells, respectively. Flow cytometric analysis using FOXP3 antibodies 
detecting different epitopes revealed differential expression of FOXP3 isoforms in 
CD4+CD25+ and CD8+CD25+ T cells induced from optimal and suboptimal 
stimulation. Further analysis revealed that CD4+ and CD8+ regulatory T cells from 
suboptimal stimulation highly express a FOXP3 isoform lacking exon 2 (ΔE2) and 
partially lacking exon3 (ΔpE3) preferentially localized to the nucleus, compared to those 
from optimal stimulation. Lentiviral transduction of FOXP3 isoform (full length, ΔE2, 
ΔpE3) into Jurkat T cells did not induce strong immunosuppressive function. By contrast, 
when cultured in the media generated from suboptimal stimulation, transduced Jurkat T 
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cells became more immunosuppressive, suggesting that soluble factors generated from 
suboptimal stimulation with SEC1 play an important role in induction of 
immunosuppressive Tregs. In conclusion, our data demonstrated that superantigen 
concentration determines distinct expression and subcellular localization of FOXP3 
isoforms, thereby promoting development of functional Tregs in S. aureus infection. 
4.2 Introduction 
Regulatory T cells (Tregs) represent a specific subset of T cells that play a crucial 
role in peripheral tolerance and immune homeostasis through suppression of activated 
immune cells. Tregs are derived from the thymus or converted from conventional CD4+ 
or CD8+ T cells by stimulation in the periphery or in vitro and they express the 
transcription factor forkhead box P3 (FOXP3) [29, 58, 216]. FOXP3 has been recognized 
as a master controller for the development, maintenance, and function of Tregs [21, 121]. 
Mutations in the FOXP3 gene result in a fatal recessive immune disorder termed IPEX 
(immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome in humans 
[27] and scurfy syndrome in mice [26], which indicates the critical role of FOXP3 on 
Treg function in immunoregulation. 
The FOXP3 gene contains 11 coding exons and encodes a protein consisting of 
several functional domains including a C2H2 zinc finger, a leucine zipper, and a winged-
helix/forkhead DNA binding domain. These domains are engaged in FOXP3 
oligomerization [217], DNA binding [218], or interacting with other transcriptional 
factors such as nuclear factor of activated T cells (NFAT), retinoic acid receptor-related 
orphan receptors (RORγt and RORα), and IFN regulatory factor 4 (IRF4) [36] because 
FOXP3 functions as a repressor or an activator of target genes [32, 33]. 
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FOXP3 expression in mice exclusively identifies Tregs with suppressive 
functionality [20, 121]. In humans, however, FOXP3 can be ectopically expressed in 
conventional T cells by stimulation via TCR with [119, 219] or without conferring 
suppressive capability [122, 123]. Although FOXP3 is still considered an indispensable 
regulator for suppressive Tregs in humans, the discrepancy in expression and 
functionality of FOXP3 has not been fully elucidated. Furthermore, previous studies 
described the importance of antigen concentration on the induction of Tregs from 
conventional T cells, which determines the strength of signals delivered via T cell 
receptor/CD28 co-stimulatory receptor [47, 50]. However, it is unclear how the strength 
of T cell stimulation regulates induction of functional FOXP3, eventually resulting in 
suppressive properties of Tregs. 
An additional distinct difference between murine and human FOXP3 is the 
presence of alternatively spliced FOXP3 isoforms in humans which have been identified 
as a full-length, a variant lacking exon 2 (ΔE2), a variant lacking exon 7 (ΔE7), and a 
variant lacking both exon 2 and 7 (ΔE2ΔE7) [30, 44, 124]. Transfection of naive CD4+ T 
cells with FOXP3 full-length or ΔE2 resulted in conflicting functional characteristics 
with induction of immunosuppressive Tregs [45] or failure to induce functional Tregs 
[29], respectively. It remains elusive how FOXP3 isoforms are induced and what is their 
role in development and function of Tregs. 
In our previous studies, stimulation of PBMCs with different concentration of 
superantigens induced FOXP3 expressions, but only CD4+CD25+FOXP3+ and 
CD8+CD25+FOXP3+ T cells induced from suboptimal stimulation were suppressive 
whereas the cells from optimal stimulation were not [159]. To investigate molecular 
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mechanisms underlying functional heterogeneity of FOXP3-expressing T cells induced 
from stimulation with staphylococcus superantigen, we characterized subcellular 
localization and profiles of FOXP3 isoforms, followed by evaluating functionality of 
FOXP3 isoforms. This study suggests that the strength of T cell stimulation modulates 
expression of specific FOXP3 isoforms which determine subcellular localization, leading 
to functional maturation of Tregs. 
4.3 Materials and methods 
4.3.1 PBMC isolation and stimulation 
This study was approved by the Institutional Review Board at Mississippi State 
University. Blood was obtained by venipuncture from healthy volunteers and informed 
consent was obtained from the volunteers in accordance with the protocol (13-191). 
Peripheral blood mononuclear cells (PBMCs) were isolated by gradient centrifugation 
using Histopaque 1.077 (Sigma-Aldrich, St. Louis, MO) and cultured in RPMI 1640 
medium containing 10% heat-inactivated FBS, 2mM L-glutamine, and 1% penicillin-
streptomycin (Invitrogen, Carlsbad, CA). The isolated PBMCs were stimulated with 
staphylococcal enterotoxin C1 (SEC1) at optimal (1 μg/ml) or suboptimal (1 ng/ml) 
stimulation as previously determined [159]. 
4.3.2 Immunophenotyping and flow cytometry  
To determine differential expression of FOXP3 in cells induced from SEC1 
stimulation, mAbs specific to human CD4-FITC, CD8-FITC, CD25-PE were purchased 
from BD Biosciences (San Diego, CA). mAb specific to human FOXP3-allophycocyanin 
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(clone PCH101) was purchased from eBioscience (San Diego, CA) and anti-human 
FOXP3-Alexaflour647 (clone 150D) was obtained from Biolegend (San Diego, CA).  
Cell staining for flow cytometry was performed according to the manufacturer’s 
instructions. Briefly, surface staining with anti-CD4, CD8, CD25 antibody was 
performed for 30 min at 4℃. Following surface staining, cells were fixed and 
permeabilized with the FOXP3/transcription factor staining buffer set (eBioscience) and 
stained with anti-FOXP3 antibody for 30 min at room temperature. After further washing, 
stained cells were acquired using a FACSCalibur flow cytometer equipped with 
CellQuest software (Becton Dickinson Immunocytometry Systems, San Jose, CA). Data 
were analyzed using FlowJo software (Tree Star, Ashland, OR). Fluorescence minus one 
(FMO) controls were used to verify positive expression. 
4.3.3 Protein extraction and immunoblot analysis 
Subcellular fractionations were performed using a nuclear-cytosol fractionation 
kit (NE-PER Nuclear and Cytoplasmic Extraction Reagents, Thermo-Fisher, Waltham, 
MA). Protein concentration was determined and an equal amount of protein was loaded 
onto 8 % denaturing acrylamide gel. Separated proteins were transferred to a PDVF 
membrane. The following mAbs were used to detect FOXP3 isoforms: the PCH101 clone 
(eBioscience) and the 150D clone (eBioscience), followed by HRP-conjugated anti-rabbit 
IgG (GE Healthcare). The loading control for fractionization was assessed by 
immunoblot against Erk (Cell Signaling Technology, Danvers, MA) and histone H3 




4.3.4 Fluorescence microscopy 
For confocal microscopic analysis, cells were stimulated under the indicated 
condition and stained with mAbs against AlexaFluor-conjugated FOXP3 (PCH101, 
eBioscience) or AlexaFluor488-conjugated FOXP3 (150D, eBioscience) as described 
above. Fixed and stained cells were centrifugated onto glass slides at 700 rpm for 4 min 
and mounted in VECTASHIEILD mounting media with DAPI (Vector Laboratories, 
Burlingame, CA). Images were obtained using Leica TCS SP8 confocal microscope 
(Wetzlar, Germany). 
4.3.5 Identification of FOXP3 splice variants 
Total RNA was isolated using RNeasy kits (Qiagen, Valencia, CA) from cells 
before and after stimulation with SEC1 for the indicated period and cDNA was 
synthesized using oligo(dT) primers and SuperScript III (Invitrogen) according to the 
manufacturer’s instructions. 
For non-quantitative identification of FOXP3 splicing variants, PCR was carried 
out on cDNAs using primers amplifying the FOXP3 coding DNA sequence as the 
forward primer was complementary to the region of exon 1 (5’-
CCTCTTCTTCCTTGAACCCC-3’) and reverse primer was designed at the region of 
exon 10 (5’-CAAACATGCGTGTGAACCAGTGG-3’). PCR products were cloned into 
pCR®-blunt II TOPO® Vector (Life Technologies) and subsequently sequenced. 
4.3.6 Quantification of FOXP3 splice variants 
For quantification of FOXP3 splicing variants over time, quantitative real-time 
PCR (qRT-PCR) was conducted using specific primer sets listed in Table 4.1. Before 
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calculating a relative ratio of each isoform for total FOXP3, we measured total FOXP3 
using a primer set complementary to exon 5 and the junction of exon 5 and 6. To ensure 
the isoform specificity, primers for detecting FOXP3 splice variants were designed to 
span the junctional regions. The accuracy of the primers was checked by cloned vectors 
containing each FOXP3 spliced sequence as inserts (data now shown). 
Table 4.1 Primer sets for qRT-PCR 
Primer set Primer sequences (5’→3’) Source 
Total FOXP3 GCTGGCAAATGGTGTCTG [30] 
 TGGCAGTGCTTGAGGAAG  
ΔpE3 ACATTTCATGCACCAGGTGCACCCC This study 
 ATTCCAGGCTGGCCACGTTG  
ΔE2ΔE3 TCGCAGCTGCAGGGATCAACGT This study 
 CTGTCCTTCCTG GGT GCA CTG  
ΔE2 ATCGCAGCTGCAGCTCTC This study 
 GTGGTGTGAGGCTGATCATGG  
ΔE7 CTTCCTCAAGCACTGCCA This study 
 CTTGTCGGATGATGCCTGC  
β-actin TGGCACCACACCTTCTACAATG This study 
 GTCTCAAACATGATCTGGGTCATC  
 
The qRT-PCR was performed using Power SYBR green master mix and ABI 
7500 real-time PCR system (Applied Biosystems, Foster City, CA) according to the 
manufacturer’s instructions. Threshold cycles (Ct) values were normalized to the 
expression of β-actin and the percentage of splice variants was calculated in relation to 
total FOXP3. 
4.3.7 Plasmid constructs and transfection 
 FOXP3 splice variants were constructed by overlap extension PCR using MSCV 
(Murine stem cell virus)-IRES (Internal ribosome entry site)-FOXP3-Thy1.1 (Addgene 
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plasmid #17443) used as a template with primers listed in Table 4.2 and cloned into 
lentiviral expression vector, pLenti-puro (Addgene plasmid #39481). Sequence integrity 
of the cloned FOXP3 isoforms was confirmed by DNA sequencing. HEK293T cells were 
co-transfected with FOXP3 isoform-containing lentiviral vector, psPAX2 (Addgene 
plasmid #12260), and pMD2.G (Addgene plasmid #12259) using TransIT-2020 
transfection reagent (Mirus Bio, Madison, WI). After 48 h, virus-containing supernatants 
were harvested, filtered with a 0.45 µm PVDF syringe filter, and subsequently 
concentrated by centrifugation at 20,000 x g for 90 min. 
Table 4.2 Primers for lentiviral constructs 








4.3.8 Lentiviral transduction and functional assay 
 Exogenous Foxp3 genes were introduced to Jurkat T cells by infection with 
lentiviruses at multiplicity of infection (MOI) of 5 (viruses/cell) for 24 h in the presence 
of 10 µg/ml of polybrene (Sigma). Expression of full-length Foxp3 and its splice variants 
was measured by flow cytometry. For functional assay, transduced Jurkat T cells were 
cultured in RPMI media (Normal media) or in the culture supernatant harvested from 
PBMCs stimulated under suboptimal condition (SEC1 1 ng/ml) for 6 d (conditioned 
media). The SEC1 remaining in conditioned media was removed using His-tag column 
(Supplementary figure 1). Jurkat T cells expressing FOXP3 isoforms were stained with 
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CellTrace FarRed (Invitrogen) and cocultured with CFSE-stained human naïve 
CD4+CD25- T cells at 1:1 ratio. Anti-CD3/CD28 beads were added as a stimulant. The 
proliferation of CD4+CD25- T cells was measured on day 4 using flow cytometry. 
4.3.9 Statistical analysis 
Statistical significance was analyzed using GraphPad Prism 6 software (GraphPad 
Software, Inc., La Jolla, CA). Two-tailed paired t-test and unpaired student t-test were 
employed. Statistically significant p-value is indicated in each figure description. 
4.4 Results 
4.4.1 Differential expression of FOXP3 isoforms depending on stimulation 
strength 
In our previous study, we demonstrated that FOXP3 expression was commonly 
induced by optimal and suboptimal stimulation with SEC1 whereas the acquisition of 
suppressive properties was exclusively observed in CD8+CD25+ T cells and 
CD4+CD25+ T cells induced from the suboptimal stimulation condition. Therefore, we 
hypothesized that FOXP3 proteins expressed by suboptimal and optimal stimulation may 
have different isoforms, which determine functionality of FOXP3. To identify the 
presence of FOXP3 isoforms, we measured expression level of FOXP3 isoforms by flow 
cytometry using two different clones of FOXP3 antibodies: the PCH101 clone which 
recognizes a common region of FOXP3 across all known isoforms and the 150D clone 
which specifically recognize an epitope encoded by exon 2. In CD4+CD25+ T cells, the 
level of FOXP3 expressions detected by the PCH101 clone and the 150D clone showed a 
significant difference in CD4+CD25+ T cells from suboptimal stimulation (Fig. 4.1A). It 
is noteworthy that the FOXP3 expression level measured by the 150D clone is 
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significantly lower than that measured by PCH101, indicating the presence of a FOXP3 
isoform lacking the exon 2-encoding region. In contrast, no significant difference in 
FOXP3 expression measured by the PCH101 and 150D clone antibodies was observed in 
CD4+CD25+ T cells from optimal stimulation. Similarly, CD8+CD25+ T cells from 
suboptimal stimulation showed a significant difference between PCH101 and150D clone 
staining whereas cells from optimal stimulation did not (Fig. 4.1B) These results indicate 
that functional heterogeneity of FOXP3 expressing CD4+CD25+ and CD8+CD25+ T 




Figure 4.1 FOXP3 isoforms are differentially expressed depending on stimulation 
strength. 
FOXP3 expression was measured by flow cytometry and gated in CD4+ (A) and CD8+ (B) subsets. Each 
circle in the graph indicates different donors and FOXP3 expression in the same donor is connected by a 




4.4.2 Differential subcellular localization of FOXP3 isoforms depending on 
stimulation strength 
Since FOXP3 is a transcriptional factor that binds to DNA to regulate target gene 
transcription, nuclear localization of FOXP3 is essential to achieve its functionality. 
Thus, we assessed localization status of FOXP3 under optimal and suboptimal 
stimulation conditions. Immunoblot analysis using anti-FOXP3 antibody PCH101 clone 
identified several isoforms of FOXP3 in fractionated protein extracts of PBMCs 
following stimulation with suboptimal and optimal conditions (Fig. 4.2A). Noticeably, a 
49 kDa FOXP3 protein predicted as full-length FOXP3 was observed in the cytoplasmic 
fraction from both conditions. However, FOXP3 isoforms with molecular weight of 
approximately 47 kDa and 44 kDa were distinctly observed in the nuclear fraction of 
suboptimal-induced cells while no band was observed in the nuclear fraction of cells 
from optimal stimulation. The 44 kDa protein in the cytoplasmic fraction was commonly 
observed from both stimulation conditions. Next, we performed immunoblotting with the 
anti-FOXP3 antibody 150D clone which detects an exon 2-encoding region. Interestingly, 
the band intensity of the 44 kDa-form in the nuclear fraction of suboptimal-induced cells 
was significantly diminished as compared to the results with the PCH101 clone while the 
47 kDa-form was still weakly detected. The 49 kDa and 44 kDa-forms were also detected 
in cytoplasmic fraction of both cell subsets. Therefore, we assumed that the 49 kDa and 
44 kDa proteins in the cytoplasmic fraction and the 47 kDa protein in the nuclear fraction 
are FOXP3 isoforms containing an exon 2-encoding region whereas the 44 kDa protein in 





Figure 4.2 FOXP3 isoforms are differentially localized from optimal and suboptimal 
stimulation. 
(A) Immunoblot analysis of FOXP3 and fractionation controls (Erk1/2 and Histone H3) in nuclei and 
cytoplasmic extracts from stimulated (day 6) or unstimulated (day 0) PBMCs (left panel). Relative band 
intensity compared to unstimulated condition is shown (right panel). The p-value was calculated by student 
t-test and <0.05 was considered significant. (B) Confocal analysis of FOXP3 expression is shown. Cells 
were stained with FOXP3 mAb clones conjugated with AlexaFlour488 (green) and with DAPI (nuclear 
stain, blue). Scale bar indicates 1µm. 
We further confirmed this result by confocal imaging analysis. Under optimal 
stimulation, FOXP3 was mostly located in the cytoplasm when stained with the PCH101 
and 150D clone antibodies (Fig. 4.2, left panel). In contrast, FOXP3 stained with 
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PCH101 was localized to the nucleus in cells from suboptimal stimulation (Fig. 4.2, right 
panel). When stained with the 150D clone, the intensity of FOXP3 signals was 
significantly reduced, indicating FOXP3 isoforms which lack an exon 2-encoding region 
are abundant in cells from suboptimal stimulation, corresponding to our results from flow 
cytometry and immunoblotting.  
Taken together, subcellular localization of FOXP3 proteins was diverse 
depending on the types of isoforms and functionality of cells, indicating the stimulation 
strength may regulate FOXP3 isoform expressions and its subcellular localization which 
leads to the functional heterogeneity of FOXP3-expressing T cells. 
4.4.3 Novel splicing variants of FOXP3 are induced by superantigen stimulation 
To further identify FOXP3 isoforms, we performed amplification of the coding 
DNA sequence of FOXP3 using cDNA prepared from CD4+CD25+ T cells induced from 
suboptimal stimulation. The amplification generated several distinct sizes of bands (Fig. 
4.3A), which were cloned and subsequently presented for DNA sequencing. The 
sequencing results showed a library of FOXP3 splice variants, not only previously 
described isoforms including FOXP3 full-length, FOXP3 lacking exon 2 (ΔE2) and 
lacking exon 7 (ΔE7), but also novel splice variants including FOXP3 lacking part of 
exon 3 (ΔpE3) and lacking both exon 2 and 3 (ΔE2ΔE3). Interestingly, FOXP3ΔpE3 
partially lacks the first 42 bp of nucleotides in exon 3, different from other splicing 




Figure 4.3 Novel splice variants of FOXP3 are induced by stimulation with SEC1. 
(A) PCR products from FOXP3 amplification were separated by agarose gel electrophoresis. FOXP3 
splicing variants identified by sequencing and size are indicated. (B) Depicted structure of FOXP3 domains 
and alternative splicing. Dotted line indicates splicing events. 
4.4.4 Dynamic changes in expressions of FOXP3 splice variants 
To determine whether expression of splice variants is regulated in a time-
dependent manner depending on the stimulation strength, mRNAs were prepared from 
PBMCs at the indicated stimulation period and expression levels of each splice variant 
were measured by qRT-PCR. Primers were designed specific to each splice variant by 
spanning splice junctions. To compare the levels of total FOXP3 expression between 
stimulation conditions, relative quantification of total FOXP3 expression was performed 
using primers recognizing common sequences across splice variants. We observed that 
the optimal and suboptimal stimulation led to upregulation of FOXP3 expression at 
comparable levels during stimulation (Fig. 4.4A). The levels of upregulated FOXP3 
expression on average were similar between stimulation conditions excluding at 48 h post 
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stimulation when the suboptimal stimulation induced a significantly higher level of 
FOXP3. Since expression of total FOXP3 mRNAs was downregulated after 72 h post 
stimulation (data not shown), subsequent quantification of splice variants was performed 
for up to 72 h. 
 
Figure 4.4 Transcriptional change of FOXP3 splice variants. 
(A) Total FOXP3 was quantified by qPCR. Data were normalized to β-actin and ddCt was 
calculated from day 0. (B) Percentage of FOXP3 splice variants in total FOXP3 was measured by 
qPCR. Data are determined from three independent experiments. Statistical significance was 
calculated by student t test between stimulation conditions (*p<0.05). 
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Meanwhile, proportions of each splice variant in relation to total FOXP3 
transcripts showed active changes following the stimulation period (Fig. 4.4B). During 
stimulation FOXP3 full-length and ΔE2 were the major splice variants followed by 
ΔpE3, ΔE7 and ΔE2ΔE3 in both stimulation conditions. Interestingly, the proportion of 
ΔE2 and ΔE2ΔE3 expressions decreased after 12 h post stimulation while that of ΔpE3 
increased. Expression of ΔE7 increased and peaked at 48 h post stimulation, followed by 
a decrease at 72 h post stimulation. Comparing between stimulation conditions, we 
observed the proportion of ΔpE3 was significantly higher in suboptimal stimulation than 
in optimal stimulation at 24 h post stimulation. Overall, expressions of FOXP3 splice 
variants transcripts changed dynamically throughout the stimulation regardless of 
stimulation strength. 
4.4.5 FOXP3 full-length, ΔE2, and a novel isoform, ΔpE3 confers suppressive 
functionality which is enhanced by soluble factors produced from 
suboptimal stimulation with SEC1 
Combining results from immunoblot analysis and cDNA sequencing, we assumed 
that the 47 kDa and 44 kDa proteins detected in nuclear fraction of cells from suboptimal 
stimulation would be ΔpE3 and ΔE2, respectively, based on protein size prediction. To 
identify functionality of FOXP3 isoforms, FOXP3 splice variants (full-length, ΔpE3 and 
ΔE2) were cloned and transduced into Jurkat T cells using lentiviral system (Fig. 4.5A). 
Subsequently, we performed MLR by mixing transduced Jurkat T cells and naïve 
CD4+CD25- T cells at 1:1 ratio. Proliferation of naïve CD4+CD25- T cells in response to 
anti-CD3/CD28 beads was partially inhibited by Jurkat T cells transduced with FOXP3 
full-length, ΔpE3, and ΔE2 (Fig. 4.5C). Interestingly, ΔpE3-transduced Jurkat T cells 
showed stronger suppressive activity compared to FOXP3 full-length and ΔE2-
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transduced Jurkat T cells. Furthermore, we tested whether additional signaling affects 
development of Tregs functionality by culturing transduced Jurkat T cells in conditioned 
media made from PBMCs with suboptimal stimulation. Interestingly, the suppressive 
activity was significantly enhanced when transduced Jurkat T cells were incubated with 
conditioned media (Fig. 4.5D). These results suggest that expression of FOXP3 isoforms 
including ΔE2 and novel isoform ΔpE3 as well as additional molecules secreted under 





Figure 4.5 Suppression activity conferred by overexpression of FOXP3 full-length, 
ΔE2, and ΔpE3 was enhanced by soluble factors produced from suboptimal 
stimulation with SEC1.  
(A) Expression of FOXP3 isoforms in Jurkat T cells by lentiviral transduction were measured using flow 
cytometry. FOXP3 was stained with the PCH101 clone. (B) Transduced Jurkat T cells incubated in normal 
media or in conditioned media, collected from suboptimal stimulation condition, were stained with 
CellTrace Far Red and mixed with CFSE-labeled human primary CD4+ T cells in addition of anti-
CD3/CD28 beads. Representative figures from three independent experiments are shown. (C) Percentage of 
relative suppression (mean±SEM) was calculated from three independent experiments. Student t-test was 




Subcellular localization of FOXP3 serves an important function since FOXP3 
binds to DNA directly and regulates expressions of target genes. Previous studies have 
demonstrated that FOXP3 in activated conventional CD4+ T cells was mostly localized 
to the cytoplasm while FOXP3 in thymus-derived Tregs was more likely to be localized 
to the nucleus [42, 220]. In this study, we observed predominant nuclear localization of 
FOXP3 isoforms with the molecular weights of 47 kDa and 44 kDa in cells from 
suboptimal condition. Although nuclear import and export signals present in FOXP3 have 
been studied [41, 42], it is still unclear what regulates FOXP3 localization. It is plausible 
that FOXP3 localization is regulated by TCR signal strength in line with studies showing 
that nuclear localization of FOXP3 is enhanced by TCR/CD28 engagement [221] and 
mTOR inhibitor treatment [220]. It is also possible that other transcription factors are 
regulated by TCR stimulation strength and subsequently control FOXP3 localization by 
interaction [43]. Yet, the molecular mechanism how stimulation strength regulates 
FOXP3 localization needs to be elucidated. 
Alternative splicing generally involves exclusion of specific exon(s) as seen in 
previously identified FOXP3 splice variants such as ΔE2, ΔE7, and ΔE2ΔE7. Noticeably, 
ΔpE3 found in our study employs a distinct alternative spicing event termed alternative 3’ 
splice. When a splice site score of alternative 3’ exon was calculated using the Human 
Splicing Finder as described by Desmet et al. [222], the score (89.95) for the alternative 
spliced region of exon 3 in ΔpE3 was higher than the score (88.19) for the intron-exon 3 
junction in FOXP3 full-length. This indicates that alternative 3’ splice is likely to happen 
in exon 3 and firmly supports our finding. Meanwhile, recent studies showed that T cell 
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activation leads to altered expression of proteins responsible for immune response via 
alternative splicing [223, 224]. A recent murine study described that TCR stimulation 
strength differentially regulates expression of splicing factors, hnRNP L and hnRNP A1 
as Akt substrates [225]. Thus, it is possible that TCR stimulation strength determines 
alternative splicing of FOXP3 and other factors necessary for Tregs differentiation. 
The discrepancy in mRNA and protein expression of FOXP3 isoforms may be 
due to differential stability of FOXP3 proteins regulated by posttranslational modification 
of FOXP3, specifically polyubiquitination which results in protein degradation. TCR 
stimulation facilitate FOXP3 polyubiquitination by signaling via Akt-mTOR axis [226] 
and by shuttling histone deacetylase (HDAC) to the nucleus [227, 228]. Thus, this 
suggests further studies to identify how stimulation strength regulates stability as well as 
posttranslational modification status of FOXP3 isoform proteins, which could provide an 
insight to understand functional heterogeneity of FOXP3-expressing T cells in humans. 
From our immunoblot data, we expected that FOXP3 isoforms with molecular 
weight of 47 kDa and 44 kDa, assumed to be ΔpE3 and ΔE2, respectively, could be the 
key factors for Tregs function in line with the findings from subjects with relapsing-
remitting multiple sclerosis (RRMS) [229] and glycolysis-dependent Tregs induction 
[230]. It is noteworthy that the novel isoform ΔpE3-transduced cells inhibited 
proliferation of responder cells as effectively as FOXP3 full-length and ΔE2. These were 
previously described as major FOXP3 isoforms in humans. The presence of an exon 2-
encoding region seems necessary for Tregs functions since increased expression of ΔE2 
has been observed in inflammatory diseases with deficient functional Tregs [231, 232]. 
This is inconsistent with in vitro result in this study and others [28, 45] which showed 
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suppressive activity of ΔE2-overexpressed T cells. Still, compared to potent suppression 
by Tregs induced from suboptimal stimulation, weak suppression was observed in MLR 
with FOXP3-transduced cells. This suggests the presence of additional regulators other 
than FOXP3 to completely induce Treg function. Indeed, the suppression was enhanced 
by incubation with conditioned media which may contain Tregs differentiation factors. 
Our results suggest that soluble factors play a role in development of functional Tregs 
beyond promoting FOXP3 transcription described in IL-2 and TGF-β [55, 233]. It is also 
possible that this enhancement was not achieved by a single factor but by a combinatory 
effect of multiple soluble factors. The responsible factors and molecular mechanisms by 
which enhance suppressive functionality needs to be elucidated in future studies 
In conclusion, our findings demonstrated that the superantigen concentration 
determines induction of immunosuppressive Tregs via differential expression and 
localization of FOXP3 isoforms. Given the importance of FOXP3 on acquisition of 
regulatory functionality, further studies need to focus on a network connecting TCR 





Staphylococcus aureus is a major human pathogen that causes a wide range of 
clinical diseases from mild skin infections to life-threatening diseases. The objectives of 
this dissertation research are to determine contribution of staphylococcal superantigens 
on S. aureus pathogenesis and to identify underlying molecular mechanisms of 
immunomodulation by superantigens. The major findings are concluded as following: 
First, a low concentration of superantigen, relevant to more frequent biological 
conditions in S. aureus infection, induced immunosuppressive CD4+CD25+FOXP3+ and 
CD8+CD25+FOXP3+ Tregs. These results suggest that S. aureus may exploit Tregs-
mediated immune suppression for its prolonged colonization by secreting a low amount 
of superantigen and thereby inducing Tregs in local environment. Also, CD8+ Tregs can 
be induced via direct activation by superantigen and antigen presenting cells, 
independently from CD4+ T cells. This suggests that superantigens not only activate 
CD4+ T cells but also CD8+ T cells simultaneously, which leads to an augmented 
immunomodulatory effect. 
Second, CD4+ and CD8+ Tregs induced by suboptimal stimulation with 
staphylococcal superantigen employed galectin-1 and granzymes for their suppressive 
activity. Identifying suppression mechanism of Tregs induced from superantigens 
contributes on understanding of superantigen-induced immunosuppression. This finding 
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also highlights the role of galectin-1 on immunomodulation and suggests possibility of its 
therapeutic intervention. 
Third, FOXP3 isoforms were differentially expressed and localized by stimulation 
strength. Since FOXP3 is expressed in human T cells upon activation, the findings in this 
study firstly identified that stimulation strength controls localization of FOXP3 isoforms 
and provides insights of discrepancy in FOXP3 expressing cells. Attenuated activation of 
Akt-mTOR signal pathway was also observed, indicating this pathway is responsible for 
Treg development in humans aligned to findings in mouse counterparts, although the link 
between inactivated signals in the pathway and development of functional Tregs remains 
elusive. 
In summary, this dissertation study addresses that superantigens produced under 
colonization or chronic infection can serve as an immunomodulator for bacterial 
colonization, propagation, and eruption of highly lethal invasive diseases. The findings in 
this dissertation provide novel insights into superantigen-mediated immunosuppression 
which contributes on S. aureus pathogenesis and add to our knowledge of superantigens 
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 Gating strategy to separate CD4+CD25- responder T cells from Figure A.1
CD8+CD25+or- T cells in autologous MLR. 
After co-culturing CFSE-labeled CD4+CD25- T cells with CD8+CD25+ T cells induced from stimulation 
with SEC1 in autologous MLR, cells were stained with an anti-CD4-PE mAb. In flow cytometry analysis, 
cells positive for a PE signal (CD4+ responder cells) were gated to separate CD8+CD25+ T cells (PE 






 Phenotypic characterization of CD8+CD25+FOXP3+ T cells induced Figure A.2
from suboptimal stimulation with SEC1. 
(A) Human PBMCs depleted of CD25+ T cells were stimulated with a suboptimal stimulation 
concentration of SEC1 (1 ng/ml) for 6 days. Expression of costimulatory molecules related to regulatory T 
cells were measured by flow cytometry. Data shown are gated on CD8+ T cells. (B) Data shown are gated 
on CD8+CD25+ T cells to analyze expression of markers related to regulatory T cells in relation with 






 Phenotypic characterization of CD8+CD25+FOXP3+ T cells induced Figure A.3
from optimal stimulation with SEC1. 
(A) Human PBMCs depleted of CD25+ T cells were stimulated with an optimal stimulation concentration 
of SEC1 (1 µg/ml) for 4 days. Expression of costimulatory molecules related to regulatory T cells were 
measured by flow cytometry. Data shown are gated on CD8+ T cells. (B) Data shown are gated on 
CD8+CD25+ T cells to analyze expression of markers related to regulatory T cells in relation with FOXP3. 






 Vβ-specific induction of CD4+CD25+FOXP3+ T cells by suboptimal Figure A.4
stimulation with SEC1. 
Expressions of Vβ2 and Vβ14, representing non-specific and specific Vβ subset to SEC1 respectively, were 
measured by flow cytometry before and after stimulation with SEC1 (1 ng/ml) for 6 days. (A) Percentage 
of Vβ positive population (dark grey, upper histogram) was measured based on FMO control (light grey, 
lower histogram) and cells were gated in CD4+. (B) Percentage of Vβ positive population was measured in 





 Galectin-1 expression in CD4+CD25+ T cells from optimal stimulation. Figure A.5
Human PBMCs depleted of CD25+ T cells were stimulated with 1 µg/ml of SEC1 for 4 days and galectin-1 
expression was measured after intracellular and surface staining using flow cytometry. Data shown are 





 The remaining SEC1 in conditioned media is completely removed. Figure A.6
Conditioned media was collected from culture supernatant of PBMCs stimulated with 1 ng/ml of SEC1 
(suboptimal stimulation) for 6 days. Collected conditioned media was flown through resin column and 
remaining his-tagged SEC1 was removed by nickel-affinity binding. Human PBMCs were isolated, stained 
with CFSE, and cultured in conditioned media before and after SEC1 removal. Proliferation of cells was 





 Multiple sequence alignment of FOXP3 splice variants. Figure A.7
Nucleotide sequences identified by DNA sequencing was aligned using T-coffee [234]. FL: FOXP3 full-
length, PubFL: published nucleotide sequence of full-length FOXP3.  
